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Primary hepatocytes are of great interests and are widely applied in various 
applications including drug testing and bio-artificial liver assist device (BLAD). However, 
the major obstacle encountered in the application of primary hepatocytes is the loss of 
liver-specific functions as well as cell polarity after isolation procedure. Hepatocyte 
collagen sandwich mimics the in vivo liver architecture and provides an optimal in vitro 
environment for cells to re-establish polarity. The perfusion culture can further enhance 
cell functions since the continuous flow provides hepatocytes with nutrients and removes 
wastes and metabolites effectively from cellular local environment.  
 
This thesis has documented the implementation of hepatocyte sandwich perfusion 
culture in the application of drug testing and BLAD to solve some of the persisting 
problems. Firstly, the significance of hepatocyte polarity in maintenance of liver-specific 
functions was evaluated in the presence of model toxins. Higher liver-specific function 
was evident in the sandwich culture with intact cell polarity than that of culture with 
polarity inhibition. The results suggested that it was essential to utilize sandwich culture 
technique, which is able to re-establish cell polarity for functional maintenance, in the 
applications, such as BLAD, where hepatocytes are exposed to toxins.  
 
For BLAD, a sandwich culture based stacked-plate bioreactor was designed. The 
novel bioreactor design overcame some persistent problems of current flat plate 
configuration including cell packing density, and the regulation of flow profile. The 
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perfusion condition, such as oxygenation and flow rate, was carefully determined and 
subsequently in vitro test of the bioreactor was performed at optimal perfusion conditions. 
Hepatocytes in the bioreactor were able to restore polarity and maintained high level of 
liver-specific functions for seven days. The results suggested that further in vivo animal 
test can be performed with the sandwich culture based stacked-plate bioreactor.  
 
Drug hepatotoxicity testing requires in vitro hepatocyte culture to maintain the 
long-term and stable liver specific functions. A drug testing platform based on hepatocyte 
sandwich perfusion culture was developed. The culture parameters such as flow rate were 
carefully determined. The perfusion system could re-establish hepatocyte polarity to 
support biliary excretion and to maintain other liver specific functions, such as the 
biotransformation enzyme activities, for two weeks that extended the usable in vitro 
hepatocyte-based drug testing window. When the perfusion cultured hepatocytes from 
days 7 or 14 were used for drug testing, the APAP-induced hepatotoxicity measurements 
were more sensitive and consistent over time than the static culture control, enabling 
further exploitations in large-scale drug testing applications. 
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Liver is the key organ with metabolism, synthesis and detoxification functions in 
the body. Primary hepatocytes are of great interests and are widely applied in various 
applications including drug testing and bioartificial liver assist device (BLAD). However, 
the major obstacle encountered in the application of primary hepatocytes is the loss of 
liver-specific functions after isolation procedure. Hepatocytes in natural liver are 
polarized cells and many liver-specific functions (uptake, transport and excretion of 
metabolites) highly depend on the cell polarity [1, 2]. It is essential to re-establish 
hepatocyte polarity for long-term functional maintenance in in vitro condition. 
Hepatocyte collagen sandwich, in which hepatocytes are cultured between two layers of 
collagen gel, mimics the in vivo liver architecture and provides an optimal in vitro 
environment for cells to re-establish polarity [3, 4]. The perfusion culture can further 
enhance cell functions since the continuous flow provides hepatocytes with nutrients and 
removes wastes and metabolites effectively from cellular local environment [5]. 
 
BLAD provides an alternative treatment for patients with fulminant hepatic 
failure (FHF) so that they can gradually recover by liver regeneration or wait for liver 
transplantation [6]. The considerations of current BLAD development focus on housing 
enough number of hepatocytes in the bioreactor to exert liver-specific functions. 
However, the efficacy of current BLADs under clinical trial is far from satisfactory, 
suggesting that housing a large number of hepatocytes in the bioreactor does not 
guarantee for good cellular functions that provide effective treatment [7]. It is important 
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to create an in vitro micro-environment in the bioreactor where hepatocytes are able to re-
establish cell polarity and thus to maintain good and stable cell functions.  
 
For drug testing application, in vitro liver models are under exploration to predict 
hepatotoxicity in the early stage of new drug development [8, 9]. Many in vitro liver 
models utilize cultured primary hepatocytes with preserved liver-specific functions for 
hepatotoxicity prediction. However, the usable period of current in vitro primary 
hepatocyte culture models is relatively short, which is about 3-5 days [10-12]. Beyond 
that period, different batches of cell isolation need to be performed for drug testing, 
which may introduce batch-to-batch variation of testing results. Ideally, primary 
hepatocytes should be cultured using long-term culture techniques to maintain stable 
cellular functions so that cultured primary hepatocytes are ready for drug testing at any 
time point during the culture period to avoid inconsistency of testing results.  
 
This thesis is based on the general hypothesis that hepatocyte sandwich 
perfusion culture is able to create an optimal in vitro micro-environment to re-
establish cell polarity and liver-specific functions for the application of BLAD and 
drug testing. Firstly, the significance of hepatocyte polarity in the maintenance of liver-
specific function was evaluated in the presence of toxic metabolites that were used to 
mimic the real scenario of BLAD application where hepatocytes were exposed to toxic 
plasma from patients. Subsequently, specific bioreactors were developed to incorporate 
hepatocyte sandwich culture in the perfusion condition and were investigated according 
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to their specific applications in BLAD and drug testing. The following specific aims are 
proposed:  
 
1.1 Specific aim 1: To evaluate the significance of hepatocyte polarity in the 
maintenance of liver-specific function in exposure to toxic substances. 
Hypothesis: Hepatocyte polarity re-established in hepatocyte sandwich culture is 
important for effective removal of toxic metabolites from intracellular region and for 
hepatocyte functional maintenance in exposure to toxic substances. 
 Identify endogenous toxic substances as model toxins for cell treatment. 
 Determine the concentration of the model toxins for cell treatment. 
 Test the effect of anti-E-cadherin antibody on hepatocyte polarity inhibition in 
sandwich culture. 
 Monitor hepatocyte function in sandwich culture with and without polarity during 
toxic substances exposure. 
 
1.2 Specific aim 2: To develop and in vitro test a sandwich culture based stacked-
plate bioreactor for BLAD application 
Hypothesis: The sandwich culture based stacked-plate bioreactor is able to create optimal 
in vitro micro-environment for well-maintained liver-specific functions and is applicable 
for BLAD.  
 Increase the cell packing density in the bioreactor. 
 Design and fabricate the sandwich culture based stacked-plate bioreactor. 
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 Design the perfusion loop for the bioreactor. 
 Determine the proper perfusion condition for the bioreactor, including oxygen 
supply and flow rate.  
 Investigate the re-establishment of hepatocyte polarity in the bioreactor 
 Monitor the liver-specific functions of hepatocyte culture in the bioreactor.  
 
1.3 Specific aim 3: To develop perfusion bioreactor for hepatocyte sandwich 
culture and test drug response of hepatocyte sandwich perfusion culture using 
model drug.   
Hypothesis: Hepatocyte sandwich perfusion culture is able to maintain long-term stable 
liver-specific functions and produce consistent drug testing results at different time point 
during the culture period.  
 Design and fabricate single-chamber hepatocyte sandwich bioreactor for 
perfusion culture. 
 Determine the perfusion condition of the bioreactor, such as flow rate 
 Monitor liver-specific functions and polarity in the sandwich perfusion culture.  
 Test drug response in the sandwich perfusion culture at different time points using 
model drug.  
 
A complete review of background information related to this thesis are presented 
in Chapter 2, including liver micro-environment, functions and polarity, various in vitro 
hepatocyte culture techniques, the in vitro liver models for drug testing and current status 
of BLAD. Chapter 3 discusses the study on Specific aim 1. In chapter 4 and 5, two 
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different applications of sandwich perfusion system (BLAD and drug testing) are 
described respectively. Chapter 6 concludes the thesis and Chapter 7 makes 
recommendations for further study. Appendix of Chapter 8 provides supporting data for 
the thesis as well as preliminary results for the future study recommended in the previous 
chapter.  
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2 Background and significance 
This chapter presents the background information that will define the rationale of 
the thesis study. In vitro hepatocyte culture is widely applied in liver tissue engineering 
for multiple applications, including drug testing study and BLAD. It is also a challenging 
field due to the complexity of liver in vivo structure and functions and the difficulty in the 
maintenance of hepatocyte structure and functions in vitro. Section 2.1 summarizes 
hepatocyte micro-environment, functions and polarized structure in vivo and section 2.2 
reviews the current in vitro hepatocyte culture models, which give us the hints to 
generalize the useful designing parameters of in vitro hepatocyte culture system for drug 
testing and BLAD applications. Current drug testing models and BLAD systems are 
discussed with their limitations in section 2.3 and 2.4, respectively. We will conclude the 
rationale and significance of the thesis research in section 2.5. 
 
2.1 Hepatocytes micro-environment, functions and polarity in vivo 
2.1.1 Macro- and micro- anatomy of the liver 
Liver is the largest organ and gland in human body, which weighs about 1% of 
the body mass. It lies in the right upper quadrant of the abdominal cavity, direct contact 
with the undersurface of the diaphragm. Liver is divided into right and left lobes of about 
equal size. Total hepatic blood flow in normal adults amounts to 25% of cardiac output 
and there are two sources where liver receives its blood: the hepatic artery with one-third 
of blood supply and the hepatic portal vein with the remainder [13]. The hepatic artery is 
the major branch of abdominal aorta and contributes half of the total oxygen supply to 
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liver. The hepatic portal vein collects blood from the small intestine, colon and pancreas, 
and delivers to the sinusoids, the specialized capillaries in liver. Subsequently, the hepatic 
vein drains the venous blood from the liver to inferior vena cava. The hepatic circulation 
system allows blood with the ingested substances to be metabolized or detoxified by the 
liver before the systemic circulation. 
 
The liver lobe is further divided into functional lobules for hepatic 
microcirculation (Figure 1A): blood from both the portal venules and hepatic arterioles is 
drained to sinusoids and collected by the hepatic venules. Hepatocytes are the liver 
parenchymal cells, which are aligned in one-cell-thick plate with around twenty cells in 
length. Cell plates are separated by sinusoid (Figure 1B). The hepatocytes close to portal 
venule, or periportal hepatocytes, have different ultrastructure from those close to central 
vein, or perivenous hepatocytes, resulting in functional zonation of cells [14]. Bile 
ductules collect bile flow from bile canaliculi formed between two adjacent hepatocytes. 
There is a space of Disse between hepatocytes and sinusoidal endothelial cells. 
Substances from sinusoids can pass through fenestrated endothelial cells to reach space of 
Disse, where mass exchange between hepatocytes and sinusoids occurs. Basement 
membrane including collagen (type IV) and laminin [15] is deposited in space of Disse 
(Figure 1B), providing a support for both endothelial cells and hepatocytes. The plasma 
membrane of hepatocyte which faces to the space of Disse is a sinusoidal domain, also 
called baso-lateral domain. Microvilli formed on the sinusoidal membrane project into 
the space of Disse to contact with blood.  The canalicular domain, or apical domain, 
which embraces to form bile canaliculus by two adjacent hepatocytes, is isolated from 
 20
baso-lateral domain through tight junction (Occludin and ZO-1) [16]. Gap junction is also 
established between hepatocytes for functional communication [17]. 
 
Several features can be generalized through the observation of hepatocyte in vivo 
micro-environment. 1) Continuous flow: Hepatocyte sinusoidal membrane is exposed to 
continuous perfusion of blood which provides oxygen and nutrients to and meanwhile 
removes wastes from hepatocytes. Bile acids, cholesterol, phospholipids, bilirubin and 
other metabolites are excreted through canalicular membrane into bile canaliculus and are 
removed by hepatic bile flow [18]. 2) Cell-matrix interaction: Hepatocytes are attached to 
extra-cellular matrix (ECM) such as collagen and laminin in the space of Disse. The 
interaction provides anchorage for hepatocytes and is also involved in regulation of cell 
functions and behaviors [19]. 3) Cell-cell interaction: Hepatocytes are interconnected 
with each other to form one layer of cells. The interaction enables the formation of bile 
canaliculus and facilitates communications between hepatocytes. 
 
      
Figure 1. Micro-anatomy of the liver: (A). Liver lobule [20], (B). liver cell plate  [21] 
 
 21
2.1.2 In vivo hepatocyte structure – cell polarity 
Hepatocytes, as other epithelial cells, are highly polarized, which is defined as 
asymmetry of cell membrane with the localization of different membrane proteins and 
lipids on different membrane domains.  Its unique position in the liver served as a barrier 
between the blood and the bile and its physiological functions of substances trafficking 
between sinusoids and bile canaliculi predominantly rely on cell polarity. 
 
Generation of hepatocyte polarity 
The generation of hepatocyte polarity involves (i) the establishment of cell-cell 
and cell-matrix interaction, (ii) the organization of cytoskeleton and (iii) the sorting and 
localization of membrane proteins [22].  
 
The initiation of polarity formation is triggered by asymmetric contact of cell 
surface to a single cell or to ECM. The spatial cue helps cells to mark the contact site and 
trigger different downstream pathway to distinguish its cell domain. The cell-cell 
interaction is mediated principally by E-cadherin, a member of the Ca2+-dependent 
cadherin superfamily of transmembrane adhesive receptors. The extra-cellular domain of 
E-cadherin binds to its counterpart of the neighboring cell which then recruits the binding 
of catenin and f-actin to its intracellular domain. The components of tight junction, such 
as zonula occluden (ZO)-1, -2, -3, claudins and occludins, are recruited to the apico-
lateral boundary to form tight junction [23].  The tight junction separates apical and baso-
lateral domain to prevent intermixture of membrane proteins on different domains, and 
also serves as a gate to control the paracellular permeability which allows certain 
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molecules (e.g. water) to directly transport from sinusoids to bile canaliculi without 
entering the cells. The cell-matrix interaction is mediated by integrin superfamily of 
adhesion receptor. The cell attachment on the ECM such as collagen, fibronectin, and 
laminin plays an important role in definition and formation of apical domain. For 
example, several marker proteins of the apical domain are excluded from membrane 
domain in contact with the matrix. 
 
Both cell-cell and cell-matrix interaction trigger the binding of actin filaments to 
the adhesive machinery. The associations between adhesive complex and actin filaments 
(i) reinforce the structure of cell-cell and cell-matrix interaction, (ii) serve as a scaffold to 
recruit downstream signaling molecules so that the local cue of polarity formation can be 
propagated to the rest part of the cell. For example, integrin-ECM binding promotes the 
phosphorylation of focal adhesion kinase (FAK), which mediates the formation of focal 
adhesion and change of cell morphology. The activation of signaling proteins, such as 
mitogen-activated protein kinase (MAPK) and protein kinase C (PKC), also lead to the 
change in the gene expression level and regulate the synthesis of specific proteins to 
mediate polarity formation or to integrate as components in the membrane domain. 
Microtubule, the other type of cytoskeleton, is rearranged around the apical site after cell 
interaction is formed. The reorganization of microtubule is linked to the change of cell 
morphology and the maintenance of secretory apparatus (e.g. Golgi, apical endosome) 
distribution for protein sorting. 
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The functional polarity requires intracellular sorting and trafficking system to 
distribute proteins or lipids to their corresponding membrane domain [24]. The lipid rafts 
on the polarized membrane also play a role in baso-lateral and apical proteins trafficking 
[25]. Sinusoidal proteins are directly delivered from the Golgi complex to sinusoidal 
domain. Both direct and indirect pathways are involved in the trafficking of canalicular 
proteins or lipids. For example, multi-drug resistance P-glycoprotein (Mdr or P-gp), bile 
salt export pump (Bsep) and sphingolipid undergo a direct route from the Golgi to the 
canalicular domain. Other canalicular proteins such as Polymeric immunoglobulin A 
receptor (pIgA-R) are transported first to sinusoidal domain where a process, called 
transcytosis, brings them to the canalicular domain. 
 
Segregation and constituents of polarized membrane domains 
The cell membrane of hepatocytes can be divided into three distinct domains 
(Figure 2): (i) the basal domain which is faced to the sinusoids for mass exchange with 
the blood and can also be termed as sinusoidal domain, (ii) the lateral domain which is 
the region of direct contact with the neighboring hepatocytes to form cell-cell adhesion, 
(iii) the apical domain which is faced to the bile canaliculi for bile excretion and can be 
also termed as canalicular domain [26]. The basal and lateral domains are structurally 
continuous and are commonly termed as baso-lateral domain. Unlike other epithelial cells 
in which the apical domain is a continuous plane at the cell apex opposite to the basal 
domain, the apical domain in hepatocytes form a close compartment (the bile canaliculi) 
with the neighboring cell and only constitute ~13% of the total cell membrane area. Tight 
junction served as a structural barrier to separate baso-lateral and apical domains. Each 
 24
domain is composed of a distinct pool of functional proteins, including adhesion proteins, 
receptors and transporters. Sinusoidal uptake and biliary excretion highly depend on 
transporters to exert liver functions. 
 
 
Figure 2. Segregation of membrane domains and transporter distribution in different 
domains of the hepatocyte 
 
In the baso-lateral domain, Na+-taurocholate cotransporting polypeptides (Ntcp), 
organic anion transporting polypeptides (Oatp), some family members of multidrug 
resistance-associate proteins (Mrp), organic anion transporters (OAT) and organic cation 
transporters (OCT) are expressed [27]. Ntcp is a sodium dependent transporter for uptake 
of most conjugated bile salts and certain sulphated steroids. Oatp represents a family of 
sodium independent transporters which is responsible for transport of conjugated and 
unconjugated bile acids, neutral steroids, some organic anions such as 
bromosulphophthalein (BSP), limited organic cations, and numerous drugs. OAT and 
OCT also belong to sodium-independent uptake system. Their substrates remain to be 
found. Mrps mediate efflux and are ATP-dependent. Mrp1 is for excretion of drug-
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glutathione, -glucuronide, and -sulfate conjugates; Mrp3 is for efflux of bile salts; Mrp4 
and Mrp5 are for efflux of nucleoside analog drugs. 
In the apical domain, are localized Bsep, Mrp2, Mdr, and Cl-/HCO3- exchanger 
[28]. Bsep is the main transporter for efflux of numerous conjugated bile salts. Mdr3 
transports phosphtidylcholine while the function of Mdr1 is yet unclear. The substrates of 
Mrp2 are mostly organic anions including conjugated bilirubin, glutathione conjugates, 
Leukotriene Cr and conjugated divalent bile salts and some drugs. 
2.1.3 Hepatocyte functions in the liver 
Hepatocytes, make up approximate 78% of the liver volume, are the major cell 
type responsible for various liver functions. Some of the metabolism and synthesis 
functions highly depend on hepatocyte polarity for directing secretory products to their 
respective membrane domain. 
 
Metabolism of carbohydrate 
Hepatocytes play an important role in the maintenance of carbohydrate 
homeostasis in the blood, mainly via the process of glycogenesis (converting glucose to 
glycogen) and glycogenolysis (converting glycogen to glucose) [29]. Other type of 
carbohydrate, e.g. fructose and galactose, can also be metabolized to glycogen. Glycogen 
appears as dense granules in the cells. The regulation of the glucose level in the blood 





Metabolism of protein 
The liver is the principle site of amino acid metabolism and protein synthesis. 
Amino acids are removed from blood by hepatocytes and are used for protein synthesis or 
as an energy source via gluconeogenesis [30]. Hepatocytes can synthesize non-essential 
amino acid through trans-amination or de-amination. They also play a major role in the 
breakdown of amino acids to produce urea. 
 
The plasma proteins are predominately synthesized in the liver [31, 32]. Albumin 
is the major product by hepatocytes (120mg/kg/day). It maintains the normal blood 
oncotic pressure and serves as a carrier for endogenous (bilirubin and thyroid hormones) 
and exogenous (drugs) substances [33]. Albumin synthesis is increased by low plasma 
oncotic pressure and is decreased by cytokines. Other plasma proteins produced by 
hepatocytes includes transport proteins (lipoprotein, transferrin, transcortin), coagulation 
proteins (fibrinogen, factor II, V, VII-XIII), fibrinolysis proteins (plasminogen) and 
protease inhibitor (alpha-1-antitrypsin, alpha-2-macroglobulin). 
 
Metabolism of lipid and bile acid 
Hepatocytes are capable of fatty acid, cholesterol, triglyceride, phospholipid and 
lipoprotein synthesis. Furthermore, the production of bile acid to form bile flow is the 
major liver function [34]. Bile acids are derived from cholesterol and are the main 
components in the bile for lipid emulsification and absorption in the intestine. Bile acids 
can be recycled by hepatocytes via enterohepatic circulation, in which bile acids in the 
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blood circulated from intestine are taken up at the sinusoidal domain of hepatocytes and 
are released to the bile at the canalicular domain. 
 
Metabolism of bilirubin 
Bilirubin, which is highly toxic, is from the breakdown of hemo-containing 
compounds such as hemoglobin, myoglobin and cytochromes [35]. Unconjugated 
bilirubin, or indirect bilirubin, in the blood is taken up by hepatocytes and conjugated 
with glucuronide to be a less toxic form (named as conjugated bilirubin or direct bilirubin) 
and subsequently excreted into bile for removal. In liver failure or cholastasis cases, 
bilirubin level in the plasma is increased due to the failure of bilirubin removal from the 
bile. 
 
Metabolism of ammonia 
Ammonia is highly toxic and depends on hepatocytes for its removal. The source 
of ammonia includes amino acids, purines and pyramidines, amines and bacterial ureases 
[36]. Over 90% of ammonia is converted to urea which is then excreted by kidneys. The 
remainder is through the production of glutamine. 
 
Biotransformation of xenobiotics 
Most drugs are hydrophobic and are able to access to cellular targets leading to 
cytotoxicity. The biotransformation pathway in the hepatocytes renders these drugs with 
hydrophilicity for detoxification and subsequent removal in the bile or urine. Two distinct 
phases are involved in the biotransformation process. Phase I reaction oxidizes, reduces 
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or hydrolyzes the compounds to a more polar form which is then conjugated with an 
endogenous molecule in phase II reaction [37]. Cytochrome P-450-dependent mono-
oxygenase system (P450 or CYP), located in the microsomal compartment of the smooth 
endoplasmic reticulum, is the major enzyme system for phase I biotransformation, 
although other systems, e.g. microsomal flavin-containing mono-oxygenases, 
prostaglandin endoperoxide synthetases, esterases, epoxide hydrolases and 
dehydrogenases, are also involved. CYPs can be classified according to their gene 
families and subfamilies. For example, CYP2E1 is the enzyme involved in 
acetaminophen (APAP) metabolism. The activity of CYPs can be further induced by 
specific inducers or in the presence of large amount of agents, which is mediated by 
increased expression of the genes [38]. 
 
The functional group exposed or catalyzed in phase I reaction can serve as a 
structural locus for phase II conjugation. UDP glucuronosyl transferases (UGT), situated 
in smooth endoplasmic reticulum, are involved in the conjugation of bilirubin, bile acids, 
serotonin, sterioids and catecholamines. The cytosol sulfotransferases are specific for 
endogenous substances such as hydroxysteroids, phenolic steroids and bile acids. 
Glutathione S-transferases (GST), although less frequently employed by the liver, play a 
critical role in detoxification of electrophilic substances. All these phase II enzymes have 
an overlapping spectrum of substrates indicating that the liver can eliminate a wide range 
of xenobiotics with alternative pathways. 
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2.2 In vitro hepatocyte culture models 
Primary hepatocytes are widely used in many in vitro applications. Isolation of 
hepatocytes from the liver is achieved by two-step collagenase perfusion technique [39]. 
The isolated liver is first perfused with Ca2+-free buffer to disrupt Ca2+ dependent cell-
cell interaction, followed by the second step perfusion with collagenase-containing buffer 
to digest collagen-based cell-matrix interaction. After subsequent filtering and 
centrifugation, isolated primary hepatocytes can be obtained. However, the isolation 
procedure not only destroys cell-cell and cell-matrix interaction, but also causes 
endocytosis of membrane transporters, which results in the loss of cell polarity [40]. 
Various in vitro hepatocyte culture models have been established, which capture the 
feature of hepatocyte in vivo micro-environment (cell-cell and cell-matrix interaction).  
2.2.1 Spheroid culture 
Primary hepatocytes are able to self-assemble to form three-dimensional multi-
cellular spherical aggregates in vitro, which is termed as spheroid [41]. Spheroid 
formation has been observed in many surfaces such as galactose modified substratum 
[42], non-coated plastic surface with positive charge [43]. Spinner and rotating flask may 
facilitate the spheroid formation and thereby provide an easy and rapid way to obtain 
hepatocyte spheroid [44]. Spheroids are shown to re-establish liver-like structure 
including various intracellular organelles, extensive cell-cell interaction via tight and gap 
junction, bile canalicular formation between cells [45, 46]. In addition, spheroids also 
exhibit enhanced albumin synthesis function and CYP activities in culture for weeks.  
However, the size of self-assembled spheroids is uncontrollable, whose diameter varies 
from 50 to 500um. Oxygen and nutrients distribution in large spheroids, which is bigger 
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than 100um in diameter, is poor, resulting in low cell viability in the core of the spheroids 
[47]. In addition, spheroid detachment from substratum easily occurs because its cell-
matrix interaction is relatively weak compared with its cell-cell interaction. Therefore, 
cell loss is a crucial issue to be considered for its application [48]. 
2.2.2 2D monolayer culture 
Primary hepatocytes form monolayer when attached to surfaces coated with ECM 
such as collagen. During the first several days of culture, hepatocytes regain polarity and 
exhibit bile canaliculi–like structure between cells [49]. However, cells start to spread 
and accordingly many liver-specific functions, e.g. albumin synthesis and CYP activities, 
drop after subsequent culture days [9, 50]. Therefore, these disadvantages limit the 
monolayer in the application where long-term culture is required. 
2.2.3 Sandwich culture 
In the sandwich culture, after hepatocytes are attached as monolayer, another 
layer of extra-cellular matrix is overlaid. Collagen (type I) is most commonly used ECM 
in hepatocyte sandwich culture. Collagen sandwich culture enables hepatocytes, instead 
of spreading in the monolayer culture, to keep in a cuboidal shape. It also mimics 
hepatocyte in vivo micro-environment where hepatocytes are sandwiched between 
basement membrane in space of Disse. Hepatocyte polarity is re-established in the 
sandwich culture with exhibition of tight and gap junction, localization of canalicular 
transporters on the apical membrane, and expression of biliary excretion [51-54]. It is 
also demonstrated that liver-specific functions are maintained and enhanced in sandwich 
culture [3, 4]. This is due to the reason that the establishment of intensive cell-matrix as 
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well as cell-cell interaction in sandwich culture up-regulates the expression of liver-
specific genes [55]. Till now, sandwich configuration is widely applied as an in vitro 
culture model in drug testing and study of hepatocyte biliary excretion [56-60]. Some 
groups also tried to incorporate sandwich culture in BLAD design [61, 62]. 
2.2.4 Perfusion culture 
The perfusion culture was first applied in hepatocyte culture in the context of 
BLAD [63-65]. It is then found that hepatocyte functions, such as phase I/II 
detoxification activities, in the perfusion culture were enhanced and maintained in long 
term [66-69], mainly because cells in the perfusion culture have improved mass transfer 
in terms of better oxygen and nutrient supply and the metabolite wastes excreted by cells 
can also be removed effectively in the flow [70]. However, the perfusion culture also 
introduces fluid-induced shear stress to hepatocytes and high shear stress would cause 
detrimental effect on hepatocyte viability and functions in vitro [5, 71], while hepatocyte 
in the natural liver is shielded from the direct shear by sinusoidal endothelial cells. It is 
important to consider proper design of perfusion bioreactor and control of flow profile to 
reduce shear stress. 
 
2.3 Application of in vitro hepatocyte culture in drug testing 
2.3.1 Mechanisms of drug-induced hepatotoxicity 
The liver is the direct downstream of gastrointestinal viscera and pancreas in the 
blood circulation via the portal vein, which brings the xenobiotics absorbed in the guts to 
the liver in the concentrated form. The liver serves as the first barrier to detoxify and 
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metabolize these exogenous substances, and thus is most vulnerable to their toxic effects. 
The mechanisms of drug-induced hepatotoxicity vary due to the different intracellular 
organelles drugs target [72-75]. (1) CYP enzyme systems, although responsible for drug 
biotransformation, often produce toxic intermediates, such as electrophiles or free 
radicals [76]. Electrophiles seek electrons and form covalent bonds with its target 
substances, such as amino acid and proteins, which impair protein functions. Free 
radicals tend to target unsaturated fatty acids and cause lipid peroxidation, which affect 
the membrane integrity and result in cell rupture. (2) Some drug may also trigger immune 
reactions which lead to inflammation and further hepatotoxic effects. For example, the 
adduct formed by the covalent binding of drugs to its CYP enzymes can migrate to cell 
surface via exocytosis and trigger immune response by either the formation of 
autoantibodies or direct induction of T cell response [77]. (3) Normally, metabolites after 
detoxification are excreted via the transporters on the canalicular domain. Some drug can 
disable the transporters and inhibit the efflux activity, which cause the disease of 
cholestasis [12, 78]. The malfunction of the transporter leads to the accumulation of the 
toxic excretion products and further injury of the cells. The immune-mediated response 
can also activate cell apoptosis via the Fas pathway [79]. (4) Mitochondrion is another 
major target of toxic drugs which can disable respiratory-chain enzymes and disrupt 
mitochondrial DNA to cause anaerobic metabolism, ATP level decline, lactic acidosis 
and triglyceride accumulation [80]. The change of mitochondrial membrane potential is 
also the trigger of mitochondria-mediated apoptosis [81, 82]. The toxicity of bile acid is 
mainly exerted via apoptotic pathway [83]. (5) Apart from cell apoptosis, drug-induced 
hepatotoxicity leads to cell death via necrosis. The cause of necrosis is not fully clear and 
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can be partially explained by the increase of cytosolic calcium level due to the covalent 
binding of intracellular proteins,  lipid peroxidation or impair of ATPase (calcium pumps) 
activity. The sustained rise in calcium level disrupts actin filaments and in turn, affects 
cell membrane integrity and causes membrane blebbing. High calcium level also change 
mitochondrial membrane potential and activate degradative enzymes which both 
contribute to cell death [74]. 
2.3.2 In vitro liver models for drug testing 
Drug development is divided into three different stages: drug discovery, pre-
clinical trials (in vitro test and in vivo animal test) and clinical trials (phase 0, I, II, III and 
IV) [84]. The assessment of drug hepatotoxicity is a crucial aspect in the new drug 
development. Many drugs, e.g. troglitazone, have been pulled from the market due to the 
late discovery of their severe hepatotoxicity [72].  In order to predict hepatotoxicity in the 
early stage of drug development, different liver in vitro models have been established 
(Table 1). Perfused liver and liver tissue slice are the only two models with the close 
lobule structure to the natural liver, allowing the study of hepatotoxicity in a tissue-level 
where physiological-based toxicokinetic modeling is possible [9]. However, the cell 
viability and functions can only be maintained in a short period of time in these two 
models. The cultured hepatocytes are more commonly used in routine hepatotoxicity test 
due to its long term functional maintenance and convenience [8, 85, 86]. Apart from cell 
viability test [87, 88], assays to trace the drug metabolic pathway, such as phase I/II 
enzymes and drug transporters activity, have been established in the cultured hepatocytes 
to identify the target of drug-induce toxicity [11, 89, 90]. The imaging-based test helps to 
investigate membrane integrity, cytoskeleton distribution, organelle and protein 
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localization, lipid droplet formation, vacuolization and other morphological and structural 
changes in a spatial and temporal manner after drug treatment [54, 91]. 
 
Table 1. Advantages and disadvantages of current in vitro liver models [8, 9, 92] 
In vitro liver model Advantages Disadvantages 
Isolated perfused liver 
 
 
Close to in vivo conditions 
Liver architecture preserved 
Bile flow preserved 
Hematodynamic parameters can 
be assessed 
 
Short viable period (2-3 hr) 
Study of only a few compounds
Bile excretion decreased after 1 
to 3 hr 
No study on human liver 
Difficulty in set-up 
Liver tissue slices 
 
 
Lobular structure preserved 
Enzyme equipment preserved 
Studies on human liver possible
Studies on several compounds 
at different concentrations 
 
Limited viable period (6 hr-2 
day) 
No collection of bile possible 
Damaged cell on the edge 
High variation 
 
Isolated hepatocytes in 
suspension 
 
Various sources (whole liver or 
biopsy) 
Close to in vivo functions 
Studies on several compounds 
at different concentrations 




Short viable period (2-4 hr) 
No collection of bile possible 
 
Primary hepatocyte culture 
 
Functions expressed for several 
days in certain conditions 




Changes in phenotype 
Altered bile canaliculi 
 
Hepatic cell lines 
 
Unlimited cell number 
Some functions preserved 
 
Loss or decrease of various 
drug enzyme activities 
Genotype instability 
Transgenic cell line 
 
Easy to culture 
Available mainly for CYPs 
Unlimited cell number 




(microsomes, cytosol, S9 
fractions) 
 
Drug enzyme activities 
preserved 
Production of metabolites for 
structural analysis 
 
Cofactors required for activity 





2.4 Application of in vitro hepatocyte culture in BLAD 
2.4.1 Overview of liver failure and its treatments 
Liver failure remains a liver disease with high mortality. It is characterized by 
severe hepatocyte injure and impairment of liver function with various complications 
[93]. The term of acute liver failure (ALF) applies to patients with liver failure in whom 
there is no history of preexisting liver disease. When hepatic encephalopathy occurs 
within 8 weeks of the first symptom of acute liver failure, it is specifically termed FHF. 
Whereas hepatic encephalopathy develops in a slower fashion, these minor cases are 
called subfulminant hepatic failure. Many other complications, such as cerebral edema, 
coagulopathy, cardiovascular abnormality and renal failure, occur in FHF. The common 
cause of liver failure are hepatic virus infection, drugs and toxins induction, and other 
miscellaneous etiologies including ischemia, Wilson’s disease, acute fatty liver of 
pregnancy and Reye’s syndrome. 
 
Liver transplantation is the most definitive and effective treatment for liver failure 
so far. However, due to the scarcity of liver donors and long waiting list for liver 
transplantation, clinicians and researches are exploring alternative therapies for patients 
to bridge the time before they receive a liver transplant or before their liver regeneration 
and recovery. These treatments can be classified as biological or non-biological based on 
materials used, and as implantable or extracorporeal based on where the therapy applies. 
Isolated hepatocyte transplantation [94], implantable liver tissue constructs using tissue 
engineering techniques [95], and transgenic xenotransplantation [96] are implantable 
biological therapies. These treatments, using other transplant sources, provide patients an 
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alternative to human liver transplantation, and are still at an early stage of development 
and clinical evaluation [97]. Meanwhile, the use of animal source or cell lines may give 
rise to safety concerns of immune rejection and reaction, xenozoonosis and tumorgenicity 
[7], which require further investigation. Other therapies, such as extracorporeal whole 
liver perfusion [98], blood-purification methods [99, 100] including blood or plasma 
exchange, hemodialysis, hemofiltration, hemoadsorption using charcoal or ion exchange 
resins column and albumin dialysis, require patient’s blood to be circulated through an 
external biological or non-biological system for blood detoxification and purification. 
However, the use of extracorporeal whole liver perfusion is not widely accepted 
clinically because of technical difficulties and early functional loss of perfused liver. The 
extracorporeal non-biological liver support system, which is commercially available now, 
is the molecular adsorbent recirculating system (MARS). It is effective to remove some 
albumin-bound toxins in patient’s blood [101]. However, liver is a complex organ and 
detoxification is only one of various liver functions. These non-biological systems are 
lack of liver synthetic and metabolic functions. In this context, bio-artificial liver assist 
device, which incorporates a bioreactor with in vitro hepatocyte culture into an 
extracorporeal blood/plasma perfusion loop, is promising to use as a temporary system 
for liver function replacement to bridge patients with FHF to liver transplantation. BLAD 
is extremely important to sustain patient’s life when liver transplantation cannot be 
performed in an emergency case or when prognosis of liver transplantation is not 
satisfactory for patients with severe brain oedema [102]. 
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2.4.2 Current status of BLAD 
The use of BLAD in treatment of liver failure is based on the assumption that 
detoxification, intermediate metabolism, macromolecule synthesis function which 
patients with liver failure have lost can be provided by hepatocytes cultured in the BLAD. 
The techniques for in vitro hepatocyte cultivation become a crucial part in the 
development of BLAD. Since hepatocytes are anchorage-dependent cells, suspension 
culture is not applicable for hepatocytes in which cells will lose their differentiated 
functions within hours [68]. Membranes, microcarriers and polymeric matrix are used as 
substratum in BLAD bioreactor design for cell attachment. Engineers and researchers 
have incorporated these in vitro hepatocyte culture models in the design of bioreactor 
configuration (Figure  3) in order to maintain their differentiated functions in BLAD as 
long as possible. 
 
 
Figure 3. BLAD configurations [7]: (A). Hollow fiber, (B). Packed bed, (C). 
Encapsulation, (D). Flat plate. 
 
Hollow fiber system 
Hollow fiber system is the most common bioreactor configuration applied in 
BLAD. Generally, a hollow fiber bioreactor consists of a cylindrical column with 
hundreds of thousands of hollow fibers aligned longitudinally through the column (Figure 
3A). Cells are cultured outside the hollow fiber while culture medium or patient’s 
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blood/plasma is perfused in the fiber lumen along the hollow fiber. The hollow fibers are 
made from semi-permeable membranes, which allow mass transfer across the membrane 
between cells and medium. However, many research groups modified the basic hollow 
fiber bioreactor design for different application purposes. 
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The five BLADs under various stages of clinical trials are all based on hollow 
fiber configuration (Table 2). They used different culture techniques for cell anchorage 
outside the hollow fibers. In an extracorporeal liver-assist device (ELAD) developed by 
Sussman and colleagues, human hepatocyte cell line was directly seeded and grown to 
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confluence in the extra-luminal space of hollow fibers [106]. The Excorp Medical 
bioartificial liver support system (BLSS) used primary porcine hepatocytes which were 
mixed with collagen to infuse into hollow fiber bioreactor [107]. Collagen formed extra-
cellular matrix outside hollow fiber for hepatocytes to attach. Demetriou and coworkers 
developed HepatAssist 2000, in which collagen-coated dextran microcarriers were used 
for porcine hepatoyctes attached and were housed outside the hollow fiber in the 
bioreactor [108]. The Academic Medical Center (AMC) BLAD system loaded non-
woven hydrophilic polyester matrix in the extra-fiber region in the bioreactor for 
hepatocytes attachment. Hollow fibers were used for oxygen supply [109]. Finally, 
Gerlach and his group developed a modular extracorporeal liver support (MELS) with a 
more complex interwoven hollow fiber cartridge [110]. Three different hollow fibers 
were interwoven to form a three-dimensional framework so that sorted hollow fibers of 
each dimension can perform separate functions such as plasma inflow, plasma outflow 
and oxygen supply. Hepatocytes were cultured with collagen matrix outside, or between, 
the hollow fibers. In this design, each hollow fiber supplied nutrients for only several 
hepatocytes so that nutrients gradient in perfusion was reduced. The system also allowed 
co-culture of hepatocytes with other non-parenchymal cells to form a tissue-like structure 
and the formation of bile canaliculi was observed. 
 
There are three hollow fiber BLADs with distinct feature which are in preclinical 
or in vitro test. The LIVERx2000 system developed in Minnesota University had 
hepatocytes seeded in the lumen of a hollow fiber instead of the extra-luminal space 
while patient’s blood was perfused between fibers [112]. Jasmund et al. in Eberhard 
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Karls University developed the oxygenating hollow fiber bioreactor (OXY-HFB) in 
which hepatocytes seeding and blood perfusion were both in the extrafiber space, 
allowing direct contact of hepatocytes and blood [113]. The hollow fibers were used for 
oxygen supply and temperature control. Mizumoto and his group applied a centrifugal 
force for hepatocytes inoculation in their liver lobule-like structure module (LLS) BLAD 
so that hepatocytes formed an organoid structure in the outer space of hollow fibers [114]. 
 
Packed bed system 
Packed bed, originally used as a term in chemical engineering, refers to a hollow 
vessel that is filled with packing materials. In application of BLAD, this configuration 
can be used to fill matrix for hepatocyte attachment and perfused with medium or 
patient’s blood/plasma (Figure 3B). Researchers have explored various packing materials 
for hepatocyte entrapment, such as microchanneled polyurethane foam [115], polyvinyl 
resin cubes [66], and polyester fabric cell scaffold [116]. The radial flow bioreactor (RFB) 
BLAD system, designed in University of Ferrara, is the only packed bed configuration 
under clinical trial [111] (Table 2).  In the bioreactor, hepatocytes were entrapped within 
the woven polyester microfibers and  patient’s plasma was perfused from the center to the 
peripheral of packed bed allowing the direct contact of hepatocytes to plasma, where as 
in some other systems, the perfusion pathway was reversed. 
 
Encapsulation system 
In an encapsulation system, hepatocytes are enveloped in a polymeric matrix to 
form a small capsule and encapsulated hepatocytes are packed in a chamber for perfusion 
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(Figure 3C). Various materials have been applied to hepatocyte encapsulation, including 
hydrogels [64], alginate [63], and copolymer like hydroxyethyl methacrylate-methyl 
methacrylate (HEMA-MMA) [117]. In some systems, hepatocytes were formed 
spheroids before entrapped into a capsule [118, 119], because there were evidences 
showing that spheroid enhanced cell-cell interaction [45], facilitated the formation of 
bile-duct structure between cells [46], improved cell functions [41]. However, there are 
no BLAD of encapsulation configuration under clinical trial so far. 
 
Flat plate system 
Hepatocytes exhibit good attachment on collagen, laminin, fibronectin, or 
Matrigel and form two-dimensional monolayer when cultured on these substratum. In a 
sandwich culture, hepatocytes are sandwiched between two layers of substratum. 
Hepatocyte polarity can be re-established and differentiated functions can be maintained 
for several weeks [3, 4]. Monolayer [65] and sandwich culture [61, 62] were incorporated 
in flat plate configuration in the application of BLAD (Figure 3D). Although sandwich 
culture is considered to be one of the best in vitro hepatocyte culture models, the use of 
sandwich culture in BLAD design encounters several difficulties, including cell packing 
density and regulating flow condition such as elimination of dead volume, reducing shear 
stress, achieving uniform flow profile. Novel bioreactor design to solve these problems 
will greatly contribute to the progress of BLAD development based on sandwich culture 
techniques. 
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2.5 Current limitations and significance of the study 
Application in either drug testing or BLAD requires in vitro hepatocyte culture 
techniques to maintain good and stable liver-specific functions. Sandwich culture is able 
to re-establish cell polarity and well maintain cellular functions. Perfusion culture can 
further enhance cellular functions by improve mass transfer for effective nutrients and 
wastes exchange. Although the sandwich culture preserves many liver-specific functions 
important for drug hepatotoxicity prediction, such as phase I/II biotransformation 
functions and transporter activities, the usable window for drug testing is relatively short. 
The use of sandwich perfusion culture as an in vitro liver model for drug testing remains 
an unexplored area. For BLAD, the sandwich culture bioreactor based on flat plate 
configuration encounters various problems including cell packing density and regulation 
of flow conditions.  
 
This thesis aimed to develop bioreactors specifically for drug testing applications 
as well as BLAD to incorporate hepatocyte sandwich with perfusion culture. The 
sandwich perfusion culture would extend the usable period of in vitro hepatocyte culture 
for drug testing and produce consistent and reliable testing data during the period. The 
new bioreactor for BLAD would be able to solve some of the existing problems 
pertaining to flat plate configuration to achieve good in vitro micro-environment with 
high cell packing density and stable liver-specific functions.  
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3 The significance of hepatocyte polarity in maintenance of 
hepatocyte function in the presence of endogenous toxins 
3.1 Introduction 
Hepatocytes in BLAD application are normally exposed to medium containing 
different toxic metabolites. The in vitro culture models are required to maintained cell 
viability and liver-specific functions not only in normal culture condition, but also in the 
presence of toxic metabolites. In this context, hepatocyte polarity plays a crucial role in 
preventing accumulation of toxic metabolites in the intra-cellular region that would 
interrupt cellular activities and cause functional deterioration and cell death. For example, 
bile acids, a toxic bile component, can be absorbed from blood by hepatocytes at the 
sinusoidal domain via Ntcp and OATP1. Y-binding proteins or intracellular vesicles 
deliver bile acids from sinusoidal domain to canalicular domain, and subsequently bile 
acids can be secreted to the bile flow via canalicular transporter, Bsep [120]. Without the 
synergy of cellular machineries in baso-lateral and apical domain, bile acid transport 
would be disrupted; intracellular level of bile acids would be increased. It would 
eventually lead to bile acid initiated cell death. 
 
Hepatocyte sandwich culture was shown to re-establish cell polarity in vitro and 
to maintain long term liver-specific functions in normal condition. There is no study on 
the hepatocyte functions of the sandwich culture in the presence of toxic metabolites. 
Since our application of sandwich culture in drug testing and BLAD is highly dependent 
on the well-maintained cell functions in the real scenario where toxic metabolites are 
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present, in this chapter, we identified the type and the concentration of toxic metabolites 
for cell treatment in vitro and monitored the cell function during the treatment. We also 
used the reagent, ECCD-1, to block the polarity formation in the sandwich culture. Cell 
function of the sandwich culture without polarity formation can be studied in order to 
evaluate the role of hepatocyte polarity in the functional maintenance with the toxic 
metabolites treatment. 
 
3.2 Materials and Methods 
3.2.1 Materials 
1.5 mg/ml neutralized collagen solution was prepared by mixing 8 ml of 3 mg/ml 
Type I Bovine dermal collagen (INAMED BioMaterials Corp, Fremont, CA, USA), 1 ml 
0.1 M NaOH, 1 ml 10×PBS and 6 ml 1×PBS. Polyethylene Terephthalate (PET) film 
(0.1mm of thickness) and PET track-etched membrane (0.8 μm of pore size) were 
purchased from Goodfellow Inc. of Cambridge, UK, and SterilTech Corp, Kent WA, 
respectively. All other reagents were purchased from Sigma-Aldrich (St. Louis, MO) 
unless otherwise stated. 
3.2.2 Collagen coating 
80 μl of neutralized 1.5 mg/ml Type I Bovine dermal collagen (8 ml collagen, 1 
ml 0.1 M NaOH, 1 ml 10×PBS, 6 ml 1×PBS) from Vitrogen, Angiotech BioMaterials 
Corp. (Palo Alto, CA) was spotted onto hydrophobic petri dishes and 12 mm PET 
membranes (Millipore Corp., Billerica, MA) were placed on the droplets for 20 min 
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before being transferred into a 37°C incubator overnight for collagen gelation to occur 
(See appendix 9.1 for the comparison of collagen coating on PET and glass coverslip). 
3.2.3 Hepatocyte isolation, sandwich culture assembly and model toxin treatment 
Hepatocytes were harvested from male Wistar rats weighing 250-300 g by a two-
step in situ collagenase perfusion method. 200-300 million cells were isolated with 
viability above 90% as determined by Trypan Blue exclusion assay [39]. Freshly isolated 
rat hepatocytes (0.18×106) were seeded on the collagen-coated polymeric film with an 
exposed diameter of 9 mm for 1.5 h. Hepatocytes on the film were then immediately 
overlaid with another collagen-coated polymeric membrane to form the sandwich 
configuration, as reported by our group previously [121]. Subsequently, the sandwich 
culture was secured using the O-rings on the minusheet carriers (Minucells and 
Minutissue Vertriebs GmbH, Bad Abbach, Germany). Hepatocyte sandwiches were 
cultured with William’s E culture medium, supplemented with 1 mg/ml BSA, 10ng/ml of 
EGF, 0.5 mg/ml of insulin, 5 nM dexamethasone, 50 ng/ml linoleic acid, 100 units/ml 
penicillin and 100 mg/ml streptomycin.  
 
For model toxin treatment, cell cultures were incubated with culture medium 
containing model toxins of certain concentration starting from Day 1, which is one day 
after collagen overlay for stabilization. Culture medium with model toxins was changed 
every day until Day 7 and medium was collected for functional analysis. For inhibition of 
biliary excretion in hepatocytes, 16 μg/ml anti-E-cadherin antibody, ECCD-1 (Zymed 
Laboratories, CA) was added to the culture media immediately after cell seeding. 
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3.2.4 Preparation of unconjugated bilirubin and taurocholate as model toxins 
Taurocholate was dissolved in William’s E culture medium with respective 
concentration. Unconjugated bilirubin is highly hydrophobic, which was dissolved in 
William’s E culture medium containing 1% BSA with respective concentration. Both 
taurocholate and bilirubin solution was prepared freshly before treatment. 
3.2.5 Hepatocyte viability assays 
Cell cultures were treated with model toxins for 24 hours and then viability tests 
were performed. For taurocholate-treated cultures, MTS assay (CellTiter 96 Aqueous 
One Solution Reagent, Promega, Singapore) was used to quantify cell viability. For 
bilirubin-treated cultures, bilirubin interferes with the MTS reading since the excitation 
peaks of MTS and bilirubin are similar. AlarmarBlue assay (Invitrogen, Singapore) was 
used to quantify cell viability of bilirubin-treated cultures. The reading values of model 
toxin treated cultures were normalized to that of the controls without model toxin 
treatment. 
3.2.6 Biliary excretion of fluorescein 
For visualization of fluorescein excretion, 3 μg/ml fluorescein diacetate (FDA) 
(Molecular Probes, Eugene, Oregon) in culture media was incubated with the cultures at 
37°C for 45 min. The cultures were then rinsed and fixed before viewing under a 
confocal microscope (Fluoview 300, Olympus, Melville, NY) using a 40× water lens.  
3.2.7 Actin staining 
For visualization of actin, cells were first permeabilized with 0.1% Triton-X at 
room temperature for 10 min. The samples were then blocked with 2.5% fetal calf serum 
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(FCS) for 10 min and incubated with 0.2 μg/ml rhodamine-phalloidin at room 
temperature for 20 min.  
3.2.8 Immunofluorescence microscopy 
Primary anti-CD147 mouse monoclonal antibody was purchased from Serotec, Inc. 
(Raleigh, NC), primary anti-Mrp2 rabbit polyclonal antibody from Sigma-Aldrich and 
secondary Pacific Blue goat anti–rabbit and Alexa Fluor 635 goat anti–mouse from 
Molecular Probes (Eugene, Oregon). 3.7% paraformaldehyde-fixed samples were 
blocked in 10% FCS at room temperature for 1 h. Samples were incubated with the 
primary antibodies (1:10) overnight at 4°C, before being rinsed with 1×PBS thrice each 
lasting 5 min. Samples were then incubated with the secondary antibodies at room 
temperature for 1 h and rinsed with 1×PBS before being mounted with FluorSaveTM 
(Calbiochem, San Diego, CA). The samples were viewed with a confocal microscope 
(Fluoview 500, Olympus, Melville, NY) using 60× water lens. 
3.2.9 Hepatocyte functional assays 
Hepatocyte culture medium was collected every day and stored at -30°C until 
measurement. The albumin concentration was measured using the Rat Albumin ELISA 
Quantitation Kit (Bethyl Laboratories Inc., Montgomery, Texas). Data were normalized 
to 106 cells based on the number of seeded cells. 
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3.3 Results 
3.3.1 Identification of the endogenous toxins for cell treatment 
Two criteria were used to identify the toxins for cell treatment. First, the toxins 
should be endogenous and can be metabolized in the liver. When liver function is 
impaired, the level of these toxins in the blood would be elevated. The use of these 
substances as model toxins is to mimic the real scenario that hepatocytes experience in 
the liver failure cases. Second, the transport of these toxins into and out of the cells 
should depend on polarized cell structure so that the importance of cell polarity can be 
evaluated. There are some other toxins that were transported across the cell membrane 
not via specific transporters but via passive diffusion. If using these toxins, the 
significance of cell polarity can not be demonstrated.  
 
In the blood of FHF patients, the common endogenous toxins present are 
ammonia, creatine, merkaptans, phenols, bile acids, bilirubin [93]. Among them, only 
bilirubin and bile acids are taken up via baso-lateral domain and are excreted via 
canalicular domain into the bile flow [120, 122, 123]. High serum bilirubin level is toxic 
to brain, which disrupts neurotransmitter transport and damages mitochondria to affect 
energy metabolism and trigger apoptosis [124, 125]. Bilirubin also affect the respiratory 
activity in the lung by interference with the surfactant protein in the lung so that 
surfactant activity of the air-liquid interface is impaired [35]. Elevated serum total bile 
acid concentration, will saturate the cytosolic pool of bile acid binding protein and lead to 
apoptosis or neucrosis in a dose-dependent and hydrophobicity-dependent manner [82, 
83]. High bile acid level in blood also exerts toxic effect on cardiac performance [126]. 
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Therefore, we chose unconjugated bilirubin (the original form of bilirubin without the 
conjugation of glucuronide in hepatocytes) and taurocholate (the major bile salt in human 
bile [127] and used as a representative for total bile acids) as two model toxins in our 
toxin treatment study. 
3.3.2 Determination of the endogenous toxin concentration for cell treatment 
The concentration of the model toxins for cell treatment should be determined. It 
cannot be too low so that there would be no effective treatment, and it cannot be too high 
to cause severe cell death. To determine the concentration of unconjugated bilirubin and 
taurocholate for treatment, we first searched for physiological data as reference (Table 3). 
In healthy individuals, the serum concentration of unconjugated bilirubin and total bile 
acid is from 2 to 17uM and from 6 to 60uM, respectively, whereas in FHF patients, the 
concentration of the two toxins can reach up to 700uM and 300uM, respectively. 
 
Table 3. Concentration of unconjugated bilirubin and total bile acids in human bile and blood 
 Blood of healthy individuals Blood of FHF patients 
Unconjugated bilirubin 2-17 uM 37-719uM (~195uM) 
Total bile acids 6-60 uM <300uM (~160uM) 
 
Based on the physiological data, we further did an in vitro test to scan a wide 
range of concentrations of unconjugated bilirubin and taurochoalte in order to select one 
concentration for the subsequent treatment to study importance of polarity. We chose 
unconjugated bilirubin concentrations to be 500uM, 200uM, 100uM and 50uM, and 
taurocholate concentration to be 10mM, 1mM, 500uM, 100uM, 50uM and 10uM. Cell 
viability tests were performed after model toxin treatment for 24 hours. After 500uM 
unconjugated bilirubin treatement, the cell viability dropped to 31% (Figure 4A). Cell 
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viability was similar for the treatment of 200uM, 100uM and 50uM unconjugated 
bilirubin, which was around 60%. For 10mM taurocholate-treated cultures, the viability 
was 24%, while for 10uM treated cultures, the viability was 124% (Figure 4B). Since the 
MTS measure the dehydrogenase activity in the mitochondrial as a reference of cell 
viability, low concentration of taruocholate might activate dehydrogenase activity to be 
higher than that of the controls so that the viability was above 100%. For the rest of the 




















































































































Figure 5.  Albumin synthesis from Day 2 to Day 7 with the treatment of unconjugated 
bilirubin (A) and taurocholate (B) of difference concentrations. 
 
The concentrations of model toxins can be further narrowed down to the tolerable 
range for cells based on cell viability test, which were 50uM, 100uM and 200uM for 
unconjugated bilirubin, and 100uM, 500uM and 1mM for taurocholate. In order to select 
one concentration for each model toxin, albumin synthesis function was tested as a 
representative to study the effect of model toxin on liver-specific function. For bilirubin 
treated samples, albumin level of cell cultures treated with 200uM bilirubin was the 
lowest and dropped to almost zero on Day 7, while cultures treated with 50uM and 
100uM bilirubin maintained a low level of albumin synthesis function throughout the 
culture period (Figure 5A). For taurocholate-treated cultures, there was no statistically 
significant difference in albumin level, although albumin level of 1mM taurocholate-
treated cultures was highest on Day 4 and Day 5 (Figure 5B). Albumin synthesis of all 
cultures with taurocholate treatment was dropped to similar level on Day 6 and Day 7.  
 
In summary, hepatocyte responses to 50uM and 100uM unconjugated bilirubin 
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were similar based on cell viability and functional data, while 100uM was closer to the 
average bilirubin level in the blood of FHF patients. We chose 100uM unconjugated 
bilirubin for future cell treatment. For taurocholate, the effects of 100uM, 500uM and 
1mM on hepatocyte viability and function were similar. Since bile acid toxicity is highly 
dependent on hydrophobicity and the more hydrophobicity, the more toxic the type of 
bile acid is [83]. Taurocholate is the least hydrophobic among all type of bile acids, and 
thus is the least toxic. Although 500uM and 1mM are far more above the average level of 
total bile acids in the FHF patient blood that also contains other hydrophobic bile acids, 
hepatocyte viability was still high after treatment of these two concentrations. Therefore, 
we chose the moderate concentration of taurocholate which is 500uM for future 
experiment.  
 
3.3.3 Inhibition of hepatocyte polarity using E-cadherin function-blocking antibody 
In order to investigate the effectiveness of hepatocyte polarity on functional 
maintenance, we need to test hepatocyte functions of cell cultures without polarity 
formation during toxin treatment. E-cadherin function-blocking antibody, ECCD-1, was 
used to inhibit hepatocyte polarity formation. In a normal process of hepatocyte polarity 
genesis, E-cadherin, a transmembrane adhesion protein, of neighboring cells binds each 
other via their N-terminal in the extra-cellular domain. The cell-cell interaction initiated 
by E-cadherin triggers various downstream effects intracellularly [23]. 1) The 
intracellular domain of E-cadherin is anchored to the cytoskeleton of actin filament via 
adaptor protein including p120, alpha-, beta-catenin, vinculin, alpha-actinin [128]. 2) 
Phospholipase C (PLC), PKC, calmodulin, and MAPK are activated through a receptor 
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linked signaling cascade, which in turn phosphorylate several key molecules involved in 
tight junction complex formation. These molecules include ZO-1, ZO-2, occludin, 
cingulin. It was found in these studies that E-cadherin triggered tight junction through a 
series of complex cascades of chemical events. ECCD-1 specifically binds to the N-
terminal of E-cadherin [129]and blocks its adhesion function so that the downstream 
effects triggered by E-cadherin-dependent cell junction formation are attenuated [130, 
131]. Therefore, ECCD-1 is useful for inhibition of tight junction and hepatocyte polarity 
formation. 
 
Hepatocyte polarity was assayed on day 2 after ECCD-1 treatment. FDA 
excretion in cell culture without ECCD-1 treatment was concentrated in the cell boundary, 
whereas in ECCD-1 treated cell culture, FDA was diffusive localized in the intracellular 
domain (Figure 6A,D). F-actin was intensively deposited around bile canaliculi for 
effective biliary contraction (Figure 6B). For ECCD-1 treated cell culture, there was 
significant reduced bile canaliculus structure and actin filament deposition in the cell-cell 
boundary was also decreased (Figure 6E). The binding of ECCD-1 to the extra-cellular 
domain of E-cadherin disrupts the anchorage of actin filament to the E-cadherin 
molecules as well as cell-cell boundary region. Although the expression of apical 
transporter, Mrp2, is not inhibited by ECCD-1 (since the Mrp2 staining can still be 
observed), its localization on the apical domain is disrupted. Mrp2 was randomly 
distributed on plasma membrane in ECCD-1 treated culture, compared with the control 
culture where Mrp2 was localized in the cell-cell boundary, the apical domain (Figure 
6C,F). During repolarization process, Mrp2 is transported to baso-lateral domain before 
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final localization in the apical domain. The data suggested that the blockage of ECCD-1 
interfered with trans-trafficking process of Mrp2 to the apical domain. In conclusion, 
ECCD-1 is effective to inhibit hepatocyte polarity formation in sandwich culture. 
 
 
Figure 6. Effect of ECCD-1 on hepatocyte polarity inhibition in sandwich culture (day 2). 
FDA excretion (A), f-actin staining (B) and Mrp2 (red) and CD147 (green) co-staining (C) 
of cell culture without ECCD-1 treatment; FDA excretion (D), f-actin staining (E) and 
Mrp2 (red) and CD147 (green) co-staining (F) of cell culture with ECCD-1 treatment. 
The indices shown in the left bottom corner of A and D are the percentage of FDA 































Figure  7. The effect of ECCD-1 on albumin synthesis functions from Day 2 to Day 7. 
 
We further investigated whether the use of ECCD-1 would affect cell functions. 
Albumin synthesis function was monitored in the ECCD-1 treated culture compared with 
normal sandwich culture (Figure 7). The trend and concentration value of albumin 
synthesis was similar with and without ECCD treatment throughout the culture period, 
indicating that the albumin synthesis function was not affected by the ECCD treatment.  
3.3.4 Decrease of hepatocyte function in the polarity blockage culture during model 
toxin treatment 
Hepatocyte sandwich cultures with and without polarity blockage were treated 
with unconjugated bilirubin and taurocholate, respectively. In control samples, the peak 
of albumin level can be reached on Day 4. For bilirubin treated hepatocyte sandwich 
culture without polarity blockage, the peak was one day delayed which was on Day 5 and 
maintained at a similar level for the last two days, while for polarity blocked sandwich 
culture, there was no significant increase in the albumin level throughout the culture day, 
indicating the function was severely affected by unconjugated bilirubin (Figure 8A). For 
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taurocholate treated cultures, albumin level of the sandwich cultures without polarity 




Figure  8. Albumin synthesis function in the sandwich culture with and without polarity 
blockage by ECCD-1 in the presence of 100uM unconjugated bilirubin (A) and 500uM 
taurocholate (B) from Day 2 to Day 7. 
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We further calculated the percentage of drop in albumin synthesis level for the 
model toxin treated with respect to control cultures (Table 4). With bilirubin treatment, 
albumin level of polarity blocked cultures was dropped by 77% on Day 3 and similar 
percentage of drop was maintained for the subsequent culture period. For the sandwich 
culture with intact polarity, although percentage of drop was more than 50% on Day 3 
and Day 4, the albumin level start to increase on Day 5 until the end of the culture, 
indicating that cells were adapted to the toxic environment and albumin synthesis 
functions were gradually recovered. With the taurocholate treated cultures, percentage 
drop of albumin level in normal sandwich culture was less than 50% until Day 7, while 
albumin level was dropped by more than 50% starting from Day 4.  
 
Table 4. Percentage of drop in albumin synthesis function 
 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 
ECCD - 25% 63% 59% 42% 30% 39% Bilirubin + 
ECCD + 38% 77% 77% 70% 64% 77% 
ECCD - 26% 18% 31% 38% 40% 52% Taurocholate + 
ECCD + 21% 44% 56% 70% 61% 65% 
 
3.4 Discussion 
Both unconjugated bilirubin and taurocholate are metabolized in the hepatocytes. 
Hepatocyte with polarity is able to transport these endogenous toxins after metabolism.  
Intracellular trafficking system delivery the metabolites to the canalicular domain; 
Transporters (e.g. Mrp2 and Bsep) on the canalicular domain mediate the excretion of the 
metabolites to bile canaliculi; Actin filaments deposited around the canalicular domain 
drive the contractility of bile canaliculi to expel the metabolites to the surrounding 
environment [132]. Each step plays an equally important role in preventing the 
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accumulation of the toxins in the intracellular region. When exposed to toxic 
environment, hepatocytes with re-established polarity in vitro were able to effectively 
expel the toxins from the cells so that cells can be adaptive to the environment with less 
decrease in cellular functions. The detoxification activities can also be maintained 
normally for toxin metabolism, which would further release the toxic stress on the cells. 
However, the situation in polarity blocked culture is vicious. Cells were overwhelmed 
with intracellular build-up of toxin level. Toxins without enough binding proteins or 
trafficking vesicles are free to target different cytoplasmic organelles including 
mitochondria so that the energy system is disrupted, various cellular functions are 
impaired and cell death is triggered. Therefore, it is important to re-establish hepatocyte 
polarity in vitro for various applications in the toxic environment, including drug testing 
and BLAD.  
 
3.5 Conclusion  
In this chapter, we identified unconjugated bilirubin and taurocholate as two 
model toxins for cell treatment. We determined the concentration for cell treatment to be 
100uM for unconjugated bilirubin and 500uM for taurocholate. ECCD-1 was used to 
block polarity formation in the sandwich culture. With the treatment of model toxins, 
albumin synthesis function was significantly lower in the sandwich culture without 
polarity formation than that of normal sandwich culture. Our results indicate that it is 
important to re-establish hepatocyte polarity in vitro for various applications in the toxic 
environment. 
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4 Design and in vitro test of hepatocyte sandwich culture 
based stack-plate bioreactor for BLAD 
4.1 Introduction 
BLAD is regarded as an alternative and promising treatment for FHF. The 
concept of BLAD is to use functional hepatocytes in the extracorporeal device with blood 
circulation to replace patient liver functions. Bioreactor design is a crucial part of the 
development of BLAD in order to house hepatocytes and to long-term maintain cell 
viability and functions in vitro. Many efforts have been made in the past decades to 
develop various bioreactor configurations, among which hollow fiber configuration was 
widely applied in current BLADs under testing [63, 106, 108, 110, 112, 133, 134].  
Unfortunately, the efficacy of these BLADs was not convincing in the clinical trials. It 
suggests that housing adequate number of hepatocytes and only maintaining their 
viability in the bioreactor may not guarantee for good treatment outcome of BLADs. It is 
important to create a micro-environment in the bioreactor similar as the in vivo situation 
to achieve good cellular functions [6, 7, 103].  
 
Sandwich culture was a well-established in vitro hepatocyte culture model to 
mimic in vivo liver architecture and to re-establish hepatocyte polarity. In the previous 
chapter, we tested cell function in the sandwich culture under toxic condition using model 
toxins that were normally present in the blood of FHF patient and encountered by the 
cells in the BLAD. The results confirmed that hepatocytes can maintain higher level of 
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functions with intact polarity in the sandwich culture under toxic condition. Therefore, it 
is promising to design BLAD with better performance based on sandwich culture.  
 
There were several sandwich culture based BLAD designs proposed using flat 
plate configuration [61, 62, 69]. However, problems have not been adequately addressed 
in these designs [105]. The most important issue is cell packing density. For example, at 
least 5 billion hepatocytes were seeded into the hollow fiber based bioreactor under 
current clinical trials. However, for a full scale flat plate bioreactor, about 200 million 
hepatocytes were seeded in a single module with a surface area of 1150 cm2 (47cm × 
25cm) [61]. Thus, a total 50 modules would be required to achieve capacity of 10 billion 
cells. Furthermore, the flow condition, such as flow profile, dead volume, shear stress, 
was not properly regulated in the previous flat plate bioreactor designs.  
 
In the study, we aim to solve some of the persistent problems in the existing flat 
plate bioreactors by proposing our sandwich culture based bioreactor design. We properly 
regulated the perfusion conditions, including oxygen supply and flow rate, and conducted 
in vitro test on the bioreactor. Cell excretory and metabolic functions were monitored in 
the bioreactor.  
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4.2 Materials and methods 
4.2.1 Fabrication of galactosylated film/membrane and synthetic sandwich culture 
The galactosylated PET films and membranes were fabricated as reported 
previously in the literature by our group [135]. In synthetic sandwich culture, hepatocytes 
were seeded on the galactosylated PET film for 3 hrs to achieve full attachment. Culture 
medium containing the unattached cells was removed, and the attached hepatocytes were 
cultured in fresh medium for 1 day until the galactosylated PET track-etched membrane 
top support was overlaid. The sandwich construct was secured using the O-rings on the 
minusheet carriers. 
4.2.2 Fabrication of sandwich holders and bioreactor prototypes 
The design of different sandwich holders and bioreactor prototypes was first 
drawn using Solidworks (Solidworks, Singapore). The three-dimensional model was then 
translated into a polymeric prototype using Polyjet rapid phenotyping machine (Eden 
350TM, OBJET, Billerica, MA). 
4.2.3 Dye distribution Imaging 
Cherry Red dye (Gim Hin Lee PTE LTD, Singapore) was diluted 50 times from 
stock as a working dye solution. The cell plate holder prototype was placed in the 
bioreactor. The bioreactor was filled up with fresh water first and then dye solution was 
perfused from inlet to outlet driven by a peristaltic pump with a flow rate of 0.95ml/min. 
A serial of images were taken at different time point to monitor the profile of dye 
perfusion.   
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4.2.4 Collagen coating on big scale polymeric film/membrane 
PET film (for bottom attachment) or PET track-etched membrane (for top overlay) 
was cut into round plate with a diameter of 50mm. 600ul of 1.5 mg/ml collagen solution 
was spotted onto 60mm Petri dishes. PET film or membrane was placed on the droplet 
overnight at 4 oC before being transferred into a 37oC incubator for one hour for collagen 
gelation to occur. 
4.2.5 Cell seeding and sandwich culture 
Collagen-coated PET film was placed in 60mm Petri dish for cell seeding. 
Stainless steel O-ring (50mm of outer diameter and 45mm of inner diameter) was 
fabricated and placed on the film to prevent it from floating. 4 million freshly isolated 
hepatocytes (0.2 million/cm2) suspended in 3ml William’s E culture medium were seeded 
onto the film (regarded as Day -2). The medium was able to spread uniformly on the film 
to allow even distribution of hepatocytes within the area constrained by metal O-ring. 
Cell culture was placed into incubator cautiously and was not disturbed until the 
following day. On the second day, phase-contrast images were taken at different region 
of the film to verify the uniform cell seeding. Medium was then aspirated to remove 
unattached cells. Hepatocyte monolayer culture was overlaid with collagen coated PET 
membrane (regarded as Day -1). Metal ring was still placed on the sandwich to prevent 
floating. After additional 24 hours of stabilization, hepatocyte sandwich culture was 
assembled into the bioreactor for perfusion culture (regarded as Day 0). The static 
sandwich cultures were continued in Petri dishes for control purpose. The culture 
medium for static culture and bioreactor perfusion was 4ml and 250ml, respectively, and 
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was changed every day. Medium sample was collected daily for functional analysis. Both 
perfusion and static cultures were terminated on Day 7 for end point functional analysis. 
4.2.6 Dye quantification of perfusion culture at different flow rate 
Cherry Red dye was diluted 50 times from stock as a working dye solution. The 
bioreactor with dummy cell plates (PET film without cells clamped in the cell plate 
holder) was filled up with fresh water first and then dye solution was perfused from inlet 
to outlet driven by a peristaltic pump at different flow rate. The dye concentration was 
measured at different time point using micro-plate reader.    
4.2.7 Computational model and shear stress simulation 
Since the entire bioreactor geometry is too large and complex to model, only a 
three-dimensional fluid volume between two adjacent plates was modeled. The fluid flow 
volume between the plates has the thickness of 1 mm and a diameter of 50 mm. Both 
inlet and outlet protrusion have the height of 2 mm. The three-dimensional model was 
created and subsequently simulated using commercial Computational Fluid Dynamic 
(CFD) software, COMSOL (COMSOL AB, Stockholm, SWEDEN) version 3.5a. 
Tetrahedral meshing was used for the volume discretization resulting in a total of 45764 
nodes and 214151 elements. Linear system solver used was set as BiCGStab to 
numerically solve the steady-state Navier-Stokes equations. Fluid properties were set to 
be those of the culture medium and were modeled as an incompressible, isothermal, 
Newtonian fluid with a density of 1000 kg/cm3 and a dynamic viscosity of 1.3 mPa·s. 
Flow rates of 1, 2, 5 and 10 ml/min were simulated for comparison. Outlet boundary 
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condition was set at zero pressure outflow, while the no-slip walls boundary conditions 
were used along the walls of the model.  
4.2.8 Oxygen concentration measurement 
The oxygen concentration at the inlet and outlet of the stack-plate sandwich 
culture bioreactor was measured using a VWR Dissolved Oxygen meter (Model 4000, 
VWR Scientific Products, Singapore) every day. Before each measurement, calibration 
and zeroing were conducted according to operating manual provided by the company. 
The oxygen uptake rate (OUR) was calculated based on mass balance [136] 
2 2





C are the oxygen concentration at inlet and outlet, 
respectively. Q is perfusion flow rate. N is total cell number. The unit of OUR is 
normalized to be nmol/sec/million cells 
4.2.9 Biliary excretion of fluorescein 
3ug/ml FDA (Molecular Probes, Eugene, Oregon) in culture media was incubated 
with the cultures at 37ºC for 45 min. The cultures were then rinsed and fixed before 
viewing under a confocal microscope using a 40× water lens.  
4.2.10 Immunofluorescence microscopy 
Primary anti-CD147 mouse monoclonal antibody was purchased from Serotec, 
Inc. (Raleigh, NC), primary anti-Mrp2 rabbit polyclonal antibody from Sigma-Aldrich 
and secondary Pacific Blue goat anti–rabbit and Alexa Fluor 635 goat anti–mouse from 
Molecular Probes (Eugene, Oregon). 3.7% paraformaldehyde-fixed samples were 
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blocked in 10% FCS at room temperature for 1 h. Samples were incubated with the 
primary antibodies (1:10) overnight at 4°C, before being rinsed with 1×PBS thrice each 
lasting 5 min. Samples were then incubated with the secondary antibodies at room 
temperature for 1 h and rinsed with 1×PBS before being mounted with FluorSaveTM 
(Calbiochem, San Diego, CA). The samples were viewed with a confocal microscope 
(Fluoview 500, Olympus, Melville, NY) using 60× water lens. 
4.2.11 Actin staining 
For visualization of actin, cells were first permeabilized with 0.1% Triton-X at 
room temperature for 10 min. The samples were then blocked with 2.5% fetal calf serum 
(FCS) for 10 min and incubated with 0.2 μg/ml rhodamine-phalloidin at room 
temperature for 20 min.  
4.2.12 Hepatocyte viability assays 
Live and dead cells were visualized using calcein AM and propidium iodine (PI) 
co-staining. At the end of culture period, hepatocyte sandwiches were incubated with 
20μM of calcein AM (Molecular Probes, USA) and 50 μg/ml of PI (Molecular Probes, 
USA) diluted in William’s E culture medium for 30 minutes. After being rinsed with 
1×PBS once, cell culture was viewed with confocal microscopy using a 40× lens. Viable 
cells were stained with calcein AM while dead cell nuclei were stained with PI. MTS 
assay (CellTiter 96 Aqueous One Solution Reagent, Promega, Singapore) was used to 
quantify cell viability at each culture plate. MTS reading for both perfusion and static 
culture was normalized to the value of static culture. 
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4.2.13 Hepatocyte Functional Assays 
Culture medium in the perfusion and static culture was sampled every day from 
Day 1 to measure urea and albumin concentration. Urea concentration in the sample 
medium was measured using Urea Nitrogen Kit (Stanbio Laboratory, Boerne, Texas). 
Albumin concentration was measured using the Rat Albumin ELISA Quantitation Kit 
(Bethyl Laboratories Inc., Montgomery, Texas). The phase I and II enzyme metabolic 
functions of sandwich cultures were assayed at day 7 due to the difficulty of disassembly 
of bioreactor during the culture period. The CYP1A1/2 enzyme activities (phase I 
functional marker) were evaluated by EROD assay, in which sandwich culture were 
incubated with 39.2 mM 7-ethoxyresorufin at 37 °C for 4 h. The quantity of resorufin 
produced was measured using the Tecan microplate reader at 543nm excitation/570nm 
emission against resorufin standards. UGT activity (phase II functional marker) was 
determined by incubating 100 μM of 4-umbelliferone (4-MU) (Merck, Singapore) at 37 
°C for 4 hours, 4-umbelliferyl glucuronide (4-MUG) produced were analysed using 
capillary electrophoresis with laser induced fluorescence (CE-LIF) detection (Prince 
Technologies B.V., Netherlands) at an excitation wavelength of 325 nm. 
 
4.3 Results 
4.3.1 Increase of cell packing density in the sandwich culture configuration 
It is important to increase cell seeding density of the sandwich culture for the 
application of BLAD. However, what the maximal seeding capacity is in the sandwich 
culture and whether increasing cell seeding density in the sandwich culture would 
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influence cell polarity and functions remain unclear. Here, we explored ways to increase 
cell packing density in the sandwich culture and monitored cell polarity and functions 
accordingly. 
 
i. Cell seeding density in the sandwich culture 
Normally, cell seeding density in sandwich culture was 0.2 million cells per cm2 
to achieve ~60% confluence so that there was enough room for cells to spread and to 
migrate to form polygonal morphology and good cell-cell interaction. Here, we 
investigated three different cell seeding densities in the sandwich culture, 0.2 million 
cells/cm2, 0.3 million cells/cm2 and 0.4 million cells/cm2, to seek for the possibility to 
increase the seeding density in sandwich culture (Even higher cell seeding density to 
form double cell layer in the sandwich culture was tested and the results were presented 
in Appendix 8.2). To enhance the mass transfer property, we used synthetic sandwich 
culture instead of collagen sandwich culture, and then monitored cell polarity and 
functions. 
 
The cell morphology was visualized using f-actin staining. Bile canaliculi were 
formed between cell boundaries in the culture of 0.2 million/cm2 cell seeding density 
(Figure 9A). However, in the higher density culture of 0.3 and 0.4 million/cm2, cell shape 
was round and no bile canaliculi were observed between cell-cell boundary (Figure 9B,C). 
Hepatocyte functional polarity was assayed with FDA excretion staining on day 3 and 
Mrp2 and CD147 immuno-staining after FDA staining. In the culture of 0.2 million/cm2, 
FDA was concentrated around bile canaliculus formed between hepatocytes (Figure 10A). 
Mrp2 was localized and concentrated on the cell boundary (Figure 10D) to mediate FDA 
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transport across cell apical membrane. However, FDA was diffusively present in the 
intracellular region in the cultures of 0.3 and 0.4 million/cm2 cell seeding density (Figure 
10B,C). The distribution of Mrp2 in these two cultures was also random and overlapped 
with baso-lateral marker CD147. The data indicated that the repolarization in high 
seeding density culture was poor probably due to the limited space between the cells in 
high seeding density culture so that hepatocytes were not able to spread and flatten, and 
the formation of cell-cell interaction was thus compromised.  
 
 
Figure 9. Cell morphology in the sandwich culture with different cell density on day 3 
using f-actin staining (A-C) and phase contrast images (D-F). (A),(D). 0.2 million/cm2 




Figure 10. Hepatocyte functional polarity on day 3. FDA (Green) staining (A-C) and 
Mrp2 (Red)/CD147(Green) co-staining (D-F). (A),(D). 0.2 million/cm2. (B),(E). 0.3 
million/cm2. (C),(F). 0.4 million/cm2 
 
The total albumin synthesis functions in the culture with different cell seeding 
density were similar on day 1, whereas the culture of 0.2 million/cm2 cell seeding density, 
although its total cell number was the least among the three cultures,  produced the 
highest amount of albumin on day 3 and day 5 (Figure 11A).  The albumin level was 
increased on day 3 in the 0.2 million/cm2 culture, whereas the albumin level of the other 
two cultures with higher cell seeding density was dropped. The total urea production 
functions in the sandwich culture with 0.4 million/cm2 seeding density was the highest on 
day 1 (Figure 11B), while the urea production level of three different seeding density 
cultures was comparable on day 3 and day 5. The functional data presented here were 
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normalized to per sandwich rather than per million cells elsewhere.  
 
 
Figure 11. Albumin synthesis (A) and urea production (B) function in the sandwich 
culture with different cell seeding density from day 1 to day 5. Black bar: 0.2 million/cm2 
Grey bar: 0.3 million/cm2 White bar: 0.4 million/cm2. 
 
These results indicated that higher seeding density did not guarantee for better cell 
functions. Although some functions of the high seeding density culture was higher in the 
initial period, the functional level was gradually dropped afterwards. Since hepatocytes 
with good polarity were able to maintain long-term liver specific functions, the sandwich 
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culture with high cell seeding density was not able to re-establish cell polarity so that its 
cell functions were not as good as the culture with polarity re-establishment but lower 
cell seeding density. It suggested that there is a balance between cell number and cell 
polarity in the sandwich culture for good and long-term cell functions. Seeding more cells 
in the sandwich culture does not produce higher functions but compromise cell polarity. 
When the seeding density in the sandwich culture was increased, the functional level per 
cell actually dropped. Therefore, the cell density to be used in the following experiments 
for cell seeding in the sandwich culture was 0.2 million/ cm2.  
 
ii. Folded square double-layer sandwich culture 
Since it is not scientifically possible to increase cell packing density by seeding 
more cells in the sandwich culture, we had to explore alternative new methods technically 
in the way of bioreactor configuration design. Here we proposed to use double-layer 
sandwich to achieve higher packing density. In the flat plate configurations found in 
literatures, the flat cell plate just consisted of one layer of sandwich culture. If we use 
double-layer sandwich culture in a single cell plate, the cell number could be doubled.  
 
Figure 12 illustrated how to achieve double-layer sandwich culture by folding 
method. The sandwich culture was designed to be square. Hepatocytes were seeded on 
individual non-porous PET film coated with collagen. The porous PET membrane was 
cut to be long enough so that it can cover two PET films. The PET membrane was also 
coated with collagen before overlay.  During the overlay process, the two PET films were 
placed on the PET membrane shoulder by shoulder with a little space in between for 
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folding (Figure 12A). The cells on the PET film were faced down and the collagen coated 
surface of the PET membrane was faced up so that cells had direct contact with collagen 
layer on the film or membrane (Figure 12B). Subsequently, the long PET membrane with 
two PET films on top was folded in such a way that the two PET films were faced to each 
other to form a double-layer sandwich culture (Figure 12C).  Although the idea of 
“folding sandwiches” sounded interesting, the folding method was difficult in handling. 
For example, it is difficult to place two films properly on the long membrane with 
consistent space in between. The precise alignment of two films was also demanding and 
time-consuming, which was not applicable to handle large numbers of sandwiches for 
BLAD. Therefore, this folding method was terminated from further exploration.  
 
 
Figure 12. The schematic of folded square double-layer sandwich culture. (A). Top view 
of the sandwich culture before folding. (B). Front view of sandwich culture before 
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Figure  13. The schematic of round aligned double-layer sandwich assembly.  
 
iii. Round aligned double-layer sandwich culture 
The double-layer sandwich culture can also be simply achieved by alignment of 
two round sandwich cultures (Figure 13). Both non-porous PET film and porous PET 
membrane were cut to be round. The round film or membrane with appropriate size could 
be easily placed in petri dish that is commercially available for cell culture.  Hepatocytes 
were seeded on collagen coated non-porous film and overlaid with collagen coated 
porous membrane, same as the normal practice for sandwich culture. Two single 
sandwich cultures were aligned in such a way that the two bottom non-porous films were 
faced to each other (Figure 13). To assemble double-layer sandwich by alignment is 
much easier than that by folding method, since the practice was simply to put one 
sandwich on the top of another one. Thus, by using aligning method, we technically 
solved the problem to realize the double-layer sandwich that doubled the cell packing 
density for the flat plate configuration.  
Porous PET membrane 
Porous PET membrane 




Figure  14. (A). Cell seeding on collagen coated PET membrane immobilized with metal 
ring in 60mm Petri dish. (B). Hepatocyte morphology on the central region of PET 
membrane 24 hours after seeding.  (C). Hepatocyte morphology on the region between 
center and periphery of PET membrane 24 hours after seeding. (D). Hepatocyte 
morphology on the peripheral region of PET membrane 24 hours after seeding. 
 
Conventional sandwich culture was normally conducted in 24-well plates or tissue 
culture flasks where collagen is directly coated on the plate bottom or flask bottom before 
cell seeding. However, in our application, we would seed the cells on large-scale 
polymeric film (50mm in diameter). The film tended to float in the presence of the 
culture medium so that cell attachment on the film would not be uniform. In order to 
solve this problem, we fabricated a stainless steel ring to immobilize the film in the Petri 
dish (Figure 14A). During seeding, culture medium with suspended cells was pipetted on 




film surface. Cell attachment on different region of the film was uniform 24 hours after 
cell seeding (Figure 14B-D). Hepatocytes formed extensive cell-cell interaction; and bile 
canaliculi network can be observed. The top layer of collagen-coated polymeric 
membrane was overlaid to form the sandwich culture one day after cell seeding. 
Subsequently, the double-layer sandwich would be assembled before placed into 
bioreactor for perfusion.  
4.3.2 Design of cell plate holder 
Cell plate holder is required to secure the double-layer sandwich culture to be 
placed in the bioreactor. Three different holder designs were explored. The first type of 
holder was axis-dependent (Figure 15A).  The holder composed of two interlock frames 
and the double-layer sandwich can be clamped in between. The axis can pass through the 
central hole in the holder to join all the holders together. Four spokes, like the wheel, 
connected the central hole with the rim of the holder. The open space between spokes 
allowed the contact of sandwich culture with the culture medium. The distance between 
neighboring holders on the axis can be adjusted so that culture medium can be perfused 
between the holders. The diameter of holder prototype was designed to allow hepatocyte 
sandwich cultured in 24-well plate to fit in (All holders were designed and tested in small 
scale before scale-up). There are some disadvantages of this design. Firstly, a hole in the 
center of the sandwich culture needs to be created so that the axis can pass through, 
which may disturb the cells and increase the complexity of film and membrane 
preparation. Secondly, the distance between neighboring holders can not be adjusted 
accurately which lead to inconsistency and variation in flow conditions. Thirdly, to 
connect each holder along the axis was difficult to handle in large scale and was also 
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time-consuming. Fourthly, the spoke, although it can be made thinner, covered some of 
the cell surface and reduced the contact area between cells and culture medium. 
Therefore, this design might not be suitable.  
 
Figure  15. (A). The prototype of axis-dependent cell plate holder. (B). The prototype of 
single unit of rod-supported cell plate holder.  (C). The final assembly of four rod-
supported cell plate holder. (D). The model of stackable cell plate holder.  
 
The second type was rod-supported cell plate holder (Figure 15B). The four rods 
on the edge was used to connect neighboring cell plates and created a fixed distance in 
between. There was a circular extrusion on the rim of top round plate whose inner 
diameter was equal to the outer diameter of the bottom round plate and whose height was 
the same as the height of the bottom round plate, so that two holders can be stacked 
together and secured (Figure 15C). There was a big opening in the center of the top and 
bottom plate and its diameter was a bit smaller than that of the sandwich culture so that 
the sandwich culture can be clamped between the holder plates. The advantages of this 
design over the axis-dependent design are obvious. Firstly, since holders are connected 
by the rods, there is no need to create a hole for the axis in the center and the sandwich 




culture can be kept intact. Secondly, almost the whole area of sandwich culture was 
exposed to the culture medium because there was no spoke. Thirdly, the distance between 
neighboring holders were maintained by the supporting rods and can be adjusted by 
change the length of the rods. The rod-supported design also made holder assembly easy 
for handling.  
 
The third type of holder was further modified based on the rod-supported type. 
The holder set consisted of two interlock parts (Figure 15D). The sandwich culture can be 
clamped and secured in between. Instead of four rods, a circular extrusion on the rim of 
the holder was made to maintain the distance between neighboring holders. A round slit 
was cut on the periphery of the holder to allow medium pass through. In this version of 
holder design, the assembly became so simple that the sandwich culture was clamped by 
the holder and was ready to be stacked together in the bioreactor.  
 
The final holder design was further modified in size to fit for the application of 
large scale sandwich culture (Figure 16).  After assembly, the holder was 56mm in 
diameter and 3mm in thickness including the circular extrusion (Figure 16C). The height 
of the circular extrusion was 0.5mm so that the distance between adjacent cell plates was 
maintained at 1mm. The width of the holder rim was reduced to be 10mm so as to 
increase the exposed area of the sandwich culture to the medium. The slit was made 
bigger so that the flow pressure near the slit was reduced. The slit would not be blocked 
by sandwich culture since the diameter of the holder where the slit was situated was 
bigger than that of the sandwich culture which was 50mm in diameter. The final 
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assembly of each cell plate allowed both sides of the double-layer sandwich face to the 
culture medium.  
 
Figure 16. Final design of cell plate holder (A). The female part of the holder. (B). The 
male part of the holder. (C). The assembly of the holder. 
 
4.3.3 Bioreactor design 
i. Inserting-based bioreactor 
Before the folded square double-layer sandwich culture was replaced by aligned 
round double layer sandwich in our experiment, a serial-flow inserting-based bioreactor 
design was proposed for folded square double-layer sandwich (Figure 17). Concave 
tracks were designed on both cover and chamber of the bioreactor for insertion and 
immobilization of sandwich plates. The folded edge of the sandwich plate was faced to 
the medium and the rest three edges were inserted into the cover, chamber wall and 
chamber bottom. The concave tracks were aligned in such a way (Figure 17C) that 
medium can flow from one plate to another (Figure 17D). However, there were some 
problems in this bioreactor design. Firstly, inserting the sandwich plate to each of the 
concave track was time-consuming, and the track itself was not tight enough to fix the 
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sandwich plate and leakage problem may occur. After the sandwich plates were seated in 
the bioreactor chamber, to fit their top edges into the track on the top cover of the 
bioreactor all together was even difficult. Secondly, the square design of bioreactor 
chamber may cause dead volume during perfusion. Since the sandwich plates were 
placed vertically, the flow would not spread evenly through the whole area of cell plate 
but flow towards the next plate before building up to cover the current plate. Therefore, 
this bioreactor design, together with the square folded double-layer sandwich, would not 
be utilized in our BLAD configuration. 
 
 
Figure 17. The schematic of serial -flow vertical-insert bioreactor. (A). The cover of the 
bioreactor. (B). The bioreactor chamber. (C). Final assembly of the bioreactor. The hole 
is for screw.  (D). The designed flow path in the bioreactor from top view. Red arrow 









ii. Stack-plate bioreactor 
A cylindrical bioreactor was designed for round double-layer sandwich plates 
(Figure 18). During the placements of the plates into the bioreactor chamber, the slit of 
each holder was placed directly opposite to those of its adjacent partners (Figure 18A). 
The slit design and its placement configuration allowed the serial flow of culture medium 
through each sandwich culture plate without bypass flow. The bioreactor was a 
cylindrical chamber and cell plates can be easily stacked into the bioreactor (Figure 18B). 
The inner diameter of the bioreactor was 58mm and the outer diameter was 80mm. The 
bioreactor had a total length of 90mm so that 13 cell plates of double-layer sandwich with 
100 million hepatocytes can be housed inside. 
 
Figure 18.  The schematic of the final design of stacked sandwich bioreactor. (A). The 
cross-section view of stacked cell plate with the placement of the slit direct opposite to 
that of its neighbouring plates. (B). Bioreactor with stacked cell plates.  
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4.3.4 Flow direction in the bioreactor 
We further studied whether the stacked cell plates were perfused vertically or 
horizontally. The bioreactor containing dummy cell plates was placed horizontally and 
the dye distribution in the bioreactor was examined (Figure 19). The flow direction was 
from right to left in the figure. The dye was observed to be denser at the lower part of the 
bioreactor near the inlet region at the third minute and the eighth minute. After fifteen 
minutes, the color of the dye near the inlet region became uniform. Similarly, the dye at 
the region near outlet was also observed to be denser at the lower part of the bioreactor at 
the fifteenth, the twentieth and the twenty-fifth minute. Dye tended to settle at the lower 
part of the bioreactor due to gravity. The mixture of the fluid at upper and lower part of 
bioreactor was mainly driven by the convectional flow while diffusion also played a role. 
Although we can not observe the dye distribution in the space between the holders which 
was blocked by the stacked extrusion on the rim of the holder, we can expect similar 
profile observed in the open space near the inlet and outlet. Therefore, flow distribution 
was not even when perfusion was performed horizontally.  
 





The bioreactor with the cell plates needs to be placed vertically (Figure 20) so that 
cells on the same cell plate can get equal opportunity to contact with the culture medium 
without the disturbance by gravity. Two dummy cell plates were placed as the first and 
the last plate in the plate stack, respectively, to regulate the serial flow. The flow was 
then directed by the slit on each cell plate to form serial flow. The culture medium 
between the cell plates had contact with both top and bottom sandwich of the adjacent 
cell plates, increasing the contact area for mass transfer between cells and culture 
medium compared with other flat plate configurations in which there was only sandwich 
culture on the bottom of perfusion chamber and medium was flowed above the sandwich.  
 
Figure 20. The illustration of flow direction (red arrows) in the bioreactor. Cell plate 
holder (Blue), double-layer sandwich culture (Pink). 
 
4.3.5 Perfusion loop set-up 
The perfusion loop comprised of a pump, a reservoir, an oxygenator unit and the 
bioreactor (Figure 21). The perfusion direction through the bioreactor was bottom-top. 
The gas permeable tubing oxygenator was placed upstream of the bioreactor. The entire 
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perfusion circuit was placed within an incubator set to a physiological temperature of 
37°C and equilibrated to either normal air atmosphere or rich oxygen atmosphere.  
 
 
Figure 21. The schematic of bioreactor perfusion loop. 
 
4.3.6 Oxygen supply for hepatocytes in the bioreactor 
Hepatocytes require high oxygen uptake to support the metabolic activities. The 
bioreactor contained approximate 100 million hepatocytes and the total oxygen 
consumption was tremendous. Since the bioreactor was perfused serially, oxygen 
gradient in the bioreactor was inevitable. The oxygen concentration in the inlet of the 
bioreactor should be high enough so that it can still support cells in the posterior of the 
perfusion path in the bioreactor after consumed by the cells in the anterior. We tested the 
cell viability in the bioreactor when the tubing oxygenator in the perfusion loop was 
exposed to normal atmosphere (95% air 5% CO2) in the incubator (Figure 22). O2 
concentration in the inlet of the bioreactor was less than 4mg/L. After three days 
perfusion, the cell viability in the perfusion culture was much lower than that in the static 
culture. The cell viability of the middle and top region in the bioreactor was even lower 
than that of the bottom region due to the oxygen gradient through the bioreactor. It 
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indicated that the oxygen supply with the exposure of the perfusion loop to the normal 
















Figure 22. Hepatocyte viability after perfusion of three days at the flow rate of 0.1ml/min. 
The coiling tubing oxygenator was exposed to normal atmosphere (95% air 5% CO2) at 
the incubator. The flow director was from the bottom to the top of the bioreactor. There 
were totally six cell plates in the bioreactor which were classified into three groups of 
two plates and labeled as bottom, middle and top based on their position in the bioreactor. 
The hepatocyte sandwich in static culture was used as control.  
 
In order to increase the oxygen concentration in the culture medium before 
entering the bioreactor, we increased the oxygen partial pressure in the incubator by using 
an oxygen tank as the extra oxygen supply for the incubator. Thus, the oxygen partial 
pressure in the incubator was raised up to 70%. Furthermore, we increased the length of 
oxygen permeable tubing in the coiling oxygenator to be 10 meters so that the residence 
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time of the culture medium in the tubing before entering the bioreactor was prolonged to 
allow enough time for oxygen equilibrium. Therefore, the oxygen concentration at the 
inlet of the bioreactor was increased to around 12 mg/L (Figure 23). After consumption 
by the cells in the bioreactor, the oxygen concentration at the outlet dropped to around 4 
mg/L. The oxygen uptake was relatively constant throughout seven days of perfusion. 
























Figure 23. The oxygen concentration at the inlet and outlet of the bioreactor when 
perfusion at flow rate of 1 ml/min 
 
High oxygen concentration may also be toxic to hepatocytes. We test whether the 
increased oxygen concentration at the bioreactor inlet was acceptable to the cells in the 
anterior position in the bioreactor. The cell viabilities of sandwich culture after one day 
incubation at normal atmosphere and at rich oxygen atmosphere were measured (Figure 
24). Almost all the cells at both conditions were viable. It suggested that the high oxygen 
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Figure 24. Cell viability at normal atmosphere (Oxygen concentration: 3.9mg/L) and at 
rich oxygen atmosphere (Oxygen concentration: 9.3mg/L). 
 
4.3.7 Determination of flow rate in the perfusion culture 
Higher flow rate improves mass transfer, but it also elevated shear stress 
experienced by the cells. Flow rate is an important parameter to be carefully determined 














































Figure 25. Dye concentration at the outlet of the bioreactor at different time point when 
perfusion at flow rate of A. 0.1 and 0.5 ml/min, B. 1, 5, 10 ml/min. The concentration 
was normalized to the concentration at the inlet to give percentage value.  
 
We first used the dye perfusion experiment to test the time for a single-pass in the 
bioreactor to investigate the dye residence time in the bioreactor. Five flow rates (0.1, 0.5, 
1, 5, 10 ml/min) were tested. The dye, when perfused at 0.1 ml/min, was measurable at 
the outlet after 10 hours (Figure 25A). After perfusion for 24 hours, the dye concentration 
at the outlet was about 30% of that at the inlet. At the flow rate of 0.5 ml/min, the dye can 
be measurable at the outlet after 1.5 hours and reached up to 60% of the inlet 
concentration after 8 hours (Figure 25A). For higher flow rate of 5 and 10 ml/min, the 
dye can be perfused through the bioreactor within 10 minutes, and the outlet 
concentration was around 60% of the inlet concentration after ~40 and ~20 minutes of 
perfusion, respectively (Figure 25B). When perfused at 1 ml/min, the dye was 
measurable at the outlet after 40 minutes perfusion and reached up to 50% of the inlet 
after 2.5 hours (Figure 25B). Therefore, 0.1 and 0.5 ml/min were too slow for the 
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perfusion culture in the serial flow configuration since the dye resided too long in the 
anterior of the perfusion path in the bioreactor which may exhaust the nutrients in the 
flow. For 10 ml/min, the perfusion may be too fast and mass transfer between cells and 
culture medium may not be effective. The mediate flow rates (from 1 to 5 ml/min) were 
reasonable for further investigation to determine the final flow rate for the perfusion 
culture. 
 
The profile of wall shear stress across the surface of the flow between two culture 
plates at different flow rates (1 ml/min, 2 ml/min, 5 ml/min, 10 ml/min) was simulated 
(Figure 26). For all flow rates, the shear stress distribution profile was similar. The 
highest shear stress was observed to be at the region near the inlet and outlet. With the 
flow spreading across the plates, wall shear stress was reduced accordingly and was 
relatively uniform in the middle region.  The maximal and average shear stress at 
different flow rates were calculated (Figure 27). Given the critical threshold of ≤33 mPa 
allowable for the hepatocytes culture [71], the wall shear stress levels generated by all 
flow rates fell within the acceptable range. However, the results from our group 
suggested that the actual threshold which is safe for hepatocytes maybe much lower than 
33 mPa. In order to reduce shear stress experienced by hepatocytes, we selected 1 ml/min 
and 2 ml/min with their average shear stress smaller than 1 mPa to be used for bioreactor 







Figure 26. The contour plot of wall shear stress across the surface of the flow between 
two culture plates at different flow rate: (A) 1 ml/min, (B) 2ml/min, (C) 5ml/min, (D) 
10ml/min. (Courtesy of Thomas Adi Kurnia Susanto) 
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Figure 27. Maximal and average shear stress at different flow rates. The values are 
shown on the top of each bar. (Courtesy of Thomas Adi Kurnia Susanto) 
 
Finally, we performed the bioreactor perfusion culture at two flow rates, 1 ml/min 
and 2 ml/min, respectively, and monitored the albumin synthesis function, so as to 
determine the flow rate for in vitro test. The albumin production level in the static culture 
was increased from day 1 to day 3. After reaching its peak on day 3, the albumin level 
was dropped (Figure 28). When perfused at 1 ml/min, the sandwich culture was able to 
maintain its peak value that was greater than the static culture until day 7 (Figure 28A). 
For the flow rate of 2 ml/min, the albumin level was lower than that of the static culture 
throughout the culture period (Figure 28B). Instead of maintaining the peak level, the 
albumin production was decreased significantly after day 3. These results suggested that 
perfusion culture at 1 ml/min maintained better albumin function than that at 2 ml/min, 
which may be due to higher shear stress resulted from higher flow rate perfusion. 





































Figure 28. Albumin synthesis function in the perfusion culture at 1ml/min (A) and 
2ml/min (B).  
 
4.3.8 Hepatocyte viability in the bioreactor after perfusion for seven days 
Cell viability in the bioreactor was assessed after perfusion at 1 ml/min for seven 
days. Almost all the cells were alive, which was stained by Calcein AM and shown in 
green, in both static (Figure 29A) and perfusion culture (Figure 29B). MTS assay was 
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used to quantify the cell viability at different plate. The total twelve cell plates in the 
bioreactor were divided into three regions (top, middle and bottom) in a group of four 
plates. Plates were randomly selected from each region for assay. Cell viability from top 
to bottom region after seven days perfusion was 99%, 97% and 90%, whereas cell 
viability in static culture was 100% (Figure 29C). There was no statistical difference of 
the cell viability for static culture as well as three regions in perfusion culture. The results 
indicated that the bioreactor was able to maintain cell viability after seven days of 
perfusion culture.  
 
 
Figure  29. Cell viability test. Calcein AM (green) and PI (red) co-staining in the static 
culture (A) and the perfusion culture (B). Cell viability quantification using MTS assay 





4.3.9 Hepatocyte biliary excretion after perfusion for seven days 
 
Figure 30. Localization of fluorescein excreted by hepatocytes in the cell boundary. (A). 
Static culture. (B). Perfusion culture in the bioreactor 
 
Hepatocyte biliary excretion was investigated in the perfusion culture at the flow 
rate of 1 ml/min after seven days compared with that in the static culture. More 
fluorescein localization around cell boundary was observed in perfusion culture than the 
static culture (Figure 30), suggesting that the transporter Mrp2, which mediated the efflux 
of fluorescein, was well-preserved in the perfusion culture.  
4.3.10 Liver-specific functions in the bioreactor 
We monitored urea production function every day after bioreactor perfusion was 
set up. Urea production rates of the perfusion culture were shown to be consistently 
higher than those in the static culture, although it dropped gradually from day 5 (Figure 
31A). The initial urea production rate of the perfusion culture from day 1 to day 4 was 
about 35 μg/million cells/day, which was more than two times higher than that of the 




Due to the difficulty of disassembly of the bioreactor during the culture period, 
phase I and phase II enzyme metabolic functions were performed after the perfusion 
culture period when incubation of the cell culture with enzyme substrate was possible. 
Both phase I (EROD activity) and phase II (UGT activity) metabolic functions were 
significantly higher on day 7 compared with the static culture (Figure 31B, C). These 
results indicated that the perfusion culture in the bioreactor can enhance the liver-specific 





Figure  31.  (A). Urea production function in the static culture and perfusion culture at 
the flow rate of 1ml/min from day 1 to day 7; (B). Phase I EROD activity on day 7; (C). 





A novel bioreactor with stacked double-layer sandwich culture was developed. 
The assembly and arrangement of cell plate holders were designed to be simple in 
handling. Other persistent problems of flat plate configuration were also addressed during 
the development. Flat plate configuration normally has a lower cell packing capacity, due 
to low surface to volume ratio, than other configurations such as hollow fiber and 
scaffolds. We made use of double-layer sandwich as single cell plate to double the cell 
packing capacity. Compared to other full-scale flat plate bioreactor with the single unit 
dimension to be 47cm × 25cm, the height and inner diameter of our cylindrical bioreactor 
unit was 10 cm and 5.5 cm, respectively; the bioreactor size was thus greatly reduced. 
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 Scalability is an important consideration in all bioreactor design for BLAD. The 
human liver normally contains ~100 billion hepatocytes, and ~10% of liver cell mass (i.e. 
10 billion hepatocytes) is suggested to be sufficient to support a single patient with liver 
failure [1]. Currently, the single unit of our bioreactor can house 100 million rat 
hepatocytes, if the cell seeding density is 0.2 million/cm2. Given that human hepatocytes 
are approximately 1.5 smaller than rat hepatocytes, the cell packing capacity can be 
increased to 150 million human hepatocytes per unit. Therefore, ~70 units are required 
for effective treatment. By doubling the existing diameter of our cell plates from 50 mm 
to 100 mm,  600 million hepatocytes can be packed in single unit and the total number of 
units required can be reduced to <20, which is reasonable and achievable.  
 
The design of perfusion flow profile is another key consideration we took efforts 
on. Dead flow is inevitable at the corner of square flat plate bioreactor.  The design of 
cylindrical bioreactor chamber was to avoid dead flow. Each plate was perfused in the 
serial flow which prolong the time for mass exchange between cells and culture medium 
along the perfusion path. Several single bioreactor units can be combined and perfused in 
a parallel manner to mimic the different liver lobes of in vivo liver (Rat has a four-lobe 
liver and human being has two liver lobes). 
 
Oxygen supply to the cells in the bioreactor 
The liver normally consumes 20% to 33% of the total oxygen in the body due to 
its high metabolic functions [136], making oxygen supply the key issue to be considered 
for bioreactor design. In the case of hypoxia, that is low oxygen environment, hepatocyte 
 99
mitochondria electron transport is limited, enzyme metabolic functions are altered and 
cell death can be resulted. The critical threshold of hypoxia can be as low as 5 mmHg (i.e. 
1.36 mg/L) [137], whereas the normal perivenous oxygen pressure is ~25 mmHg (i.e. 6.8 
mg/L) [138]. On the other hand, high surrounding oxygen level is also detrimental to 
hepatocytes. The oxidative stress imposed on mitochondria triggers signaling pathway to 
cell death [139]. The hyperoxia environment was normally created by incubating cells at 
the atmosphere of 100% or 95% O2 [140, 141]. Based on the oxygen solubility of 1.19 
nmol/ml/mmHg [136], dissolved oxygen concentration for hyperoxia is ~27mg/L (i.e. 
~490mmHg). In most hepatocyte bioreactors, the initial oxygen concentration was much 
lower than this value of hyperoxia condition. Some studies even show that hepatocyte 
exposed to higher oxygen tension ranging from 178 to 328 mmHg in the bioreactor had a 
better albumin synthesis and ammonium metabolic functions compared with normal 
oxygen tension (~100 mmHg) [66, 142].  
 
The design of serial flow in our bioreactor makes it doubtable whether the oxygen 
gradient would cause high oxygen stress on the hepatocytes near the entry of the 
bioreactor and insufficient oxygen supply to hepatocytes near the exit of the bioreactor. 
The inlet and outlet oxygen pressure in our bioreactor system were 228 mmHg and 41 
mmHg, respectively, which was well within the normoxic range. The MTS results also 
showed a uniform distribution of cell viability at different region of the bioreactor. The 
overall metabolic functions normalized to cell number in the perfusion culture were 
significantly greater than those in the static culture. Hence, it is safe to surmise that 
hepatocytes in perfusion culture did not suffer cellular damage respond to oxygen 
 100
gradient. Given the atmosphere of 70% O2 in our system, the saturation O2 concentration 
is ~20mg/L (i.e. 380 mmHg), suggesting that more oxygen can be dissolved in culture 
medium before the inlet of bioreactor and ten more culture plates can be stacked into the 
bioreactor without oxygen supply problem if OUR remains the same.  This can be 
achieved by increasing the tubing length of the oxygenator which is 10m currently, to 
allow longer residence time for oxygen transfer through the tubing membrane. 
 
The maximal OUR of hepatocyte calculated in other system and applied in many 
simulation studies was 0.38 nmol/sec/million cells [71, 138, 143]. Results showed that 
OUR was high at early phase of culture due to cellular re-organization and stabilization, 
and was dropped in the subsequent days, decreasing from 0.38 nmol/sec/million cells at 
day 1 to 0.25 nmol/sec/million cells at day 3 [136]. In addition, flow rate affected OUR. 
With flow rate increasing from 1 ml/min to 5ml/min in our bioreactor, the OUR can be 
increased from 0.046 nmol/sec/million cells to 0.38 nmol/sec/million cells. The OUR was 
also dependent on some intrinsic factors of cell culture such as hepatocyte seeding 
density and hepatocyte uptake functions [144]. Therefore, low flow rate (1 ml/min), high 
hepatocyte seeding density (0.2 million cells/cm2), and measurement of OUR after initial 
culture phase in our bioreactor system yield a lower OUR (0.046 nmol/sec/million cells). 
Compared with the static culture in our experiment in an oxygen adequate environment, 
hepatocyte viability and functions in the bioreactor were similar or even higher, 
indicating that there was no oxygen limitation issue. Our results suggested that the actual 
oxygen demand of hepatocyte culture to maintain viability and functionality would be 
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much lower than the current estimation, which may give a reference of oxygenation 
characteristics for other design of bio-artificial liver. 
 
Shear stress in the bioreactor 
With a channel height of 1 mm and a flow rate of 1 ml/min, the fluid flow through 
the chamber is considered laminar flow with an estimated Reynolds number of 0.7. The 
simulation study of wall shear stress profile indicated that elevated wall shear stresses 
were located mainly at the inlet and outlet of the flow volume because of the constriction 
of the flow area in these regions. Shear stresses level reduced gradually with the increase 
of the flow area between the two plates, where low wall shear stress values were typically 
observed at the cross-wise peripheral edge of the flow volume. It was shown in the 
literature that exposing hepatocytes to shear stresses ≤ 33 mPa was not detrimental to 
their viability or function [71, 134]. The computational data suggested that both the 
maximal and average shear stress at all flow rates (1, 2, 5 and 10 ml/min) was much 
lower the critical value (33 mPa). However, our further experimental results suggested 
that perfusion culture at 2 ml/min can not maintain well albumin synthesis function 
beyond three days. Similar observation can be obtained from the published as well as 
unpublished data of other hepatocyte perfusion systems in our group that cell viability 
and functions can not be maintained in the perfusion culture with the flow rate suggested 
in the computational simulation to be well below the critical shear stress value of 33 mPa. 
It indicated that the critical value of shear stress hepatocytes experienced to sustain its 
viability and functions could be much lower than the current value found in the literature. 
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This issue was worth further investigating. Therefore, based on our experimental data, the 
perfusion flow rate we chose for the in vitro bioreactor test was 1 ml/min.  
 
4.5 Conclusion 
In this chapter, we have proposed a design of stacked sandwich based bioreactor 
for BLAD. The design was able to overcome some persistent problems of current flat 
plate bioreactor including cell packing density, scalability and the regulation of flow 
profile. The perfusion condition of the bioreactor was carefully determined in terms of 
oxygen supply and flow rate. In vitro test showed that the bioreactors able to maintain 
high level of liver-specific functions and polarity for seven days, which can be further 
exploited in the in vivo animal model test for BLAD application. 
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5 Application of hepatocyte sandwich perfusion culture in 
drug hepatotoxicity testing 
5.1 Introduction 
The assessment of drug toxicity to liver is crucial for new drug development. The 
use of isolated hepatocytes as an in vitro liver model facilitates the prediction of 
hepatotoxicity in the early phase of drug development. Due to the scarcity of liver donors 
and the variation of liver functions among individual donors, hepatocytes from different 
batches of isolation are combined into a large cell pool so that batch-to-batch variation of 
cellular functions can be standardized [145]. The pooled hepatocytes are typically stored 
via cryopreservation; one aliquot is thawed for function validations and the rest of the lot 
is used for large-scale drug screening [146, 147]. However, many cryopreserved cells are 
not plateable (low attachment efficiency) with the loss of some important liver-specific 
functions such as transporter activities [148]. Ideally, the pooled hepatocytes should be 
cultured using long-term culture techniques to maintain stable cellular functions so that a 
small portion is used for functional validation while the rest is ready for drug testing at 
any time point during the culture period without freeze-and-thaw step. Long-term culture 
techniques can also extend the usable in vitro drug testing window so that drug treatment 
time can be long enough to yield cytotoxic effects [149]. 
 
Hepatocyte sandwich culture is widely used in drug metabolism and toxicity test 
since hepatocyte detoxicification enzyme functions and transporter activities are 
maintained in vitro.  The hepatocyte sandwich perfusion culture can further improve 
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long-term liver-specific functions in vitro, due to the improved transport of oxygen and 
nutrients to the cell surface and effective waste removal from cellular local environment. 
However, the perfusion flow would introduce the hepatocyte culture to the effect of fluid-
induced shear stress not typically encountered by the cells in natural liver where 
hepatocytes are shielded by a layer of sinusoidal endothelial cells from the direct shear of 
the blood flow. High shear stress in perfusion culture could be detrimental to hepatocyte 
viability and in vitro functions. 
 
We have developed a laminar-flow perfusion bioreactor for the sandwich culture 
that properly regulated flow parameters such as shear stress. The cultured hepatocytes 
exhibited restored cell polarity, biliary excretion and maintenance of liver-specific 
functions for two weeks. Cells could produce consistent drug toxicity responses at 
different time points during the culture allowing further exploitations in large-scale drug 
testing applications. 
 
5.2 Materials and Methods 
5.2.1 Hepatocyte perfusion culture and perfusion bioreactor 
A schematic of the flow perfusion bioreactor is shown in Figure 32. The 
bioreactor consisted of an acrylic body and top which was sealed with an O-ring. The 
culture chamber was 14.6 mm in diameter and had a channel height of 1 mm above each 
sandwich cassette in the cellular compartment. The bioreactor had an oxygen permeable 
membrane (Breathe-Easy®, Diversified Biotech, Boston, MA, USA) above the cellular 
compartment. Each bioreactor was connected by gas-permeable silicone tubing to a 
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multi-channel peristaltic pump (Ismatec SA, Glattbrugg, Switzerland) and a recirculating 
media reservoir maintained at 37°C. 
 
Figure 32 Schematic of flow perfusion bioreactor. (A): Cross-sectional view; (B): top 
view, dimensions are in mm; (C): assembled bioreactor. 
 
5.2.2 Modeling Fluid flow  
A finite element approach was adopted in order to evaluate the velocity profile 
and the mean fluid shear stress. To simulate the flow, we used the commercial CFD 
package (ANSYS Inc, Canonsburg, PA, USA) to numerically solve the steady-state 
Navier-Stokes equations. Fluid properties were set to those of the culture media and the 
culture medium was modeled as an incompressible, isothermal, Newtonian fluid with a 
density of 1×103 kg/m3 and a dynamic viscosity of 8.89×10-4 Pa·s. Flow rates of 0.1, 
0.06, 0.03 and 0.018 ml/min were simulated for comparison of mean shear stress. Outlet 
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boundary condition was set at zero pressure outflow, and the no-slip walls boundary 
conditions were used along the walls of the model. 
5.2.3 Hepatocyte functional assays 
All functional data were normalized to 106 cells based on the number of seeded 
cells. The daily albumin synthesis was measured using the Rat Albumin ELISA 
Quantitation Kit (Bethyl Laboratories Inc., Montgomery, Texas). The urea production of 
the hepatocyte cultures incubated in culture media with 2 mM NH4Cl for 90 min was 
measured using the Urea Nitrogen Kit (Stanbio Laboratory, Boerne, Texas). The 7-
ethoxyresorufin-O-deethylation (EROD) assay, which is measure of the deethylation 
activity of CYP 1A-associated monooxygenase enzymes, was initiated by incubating the 
cultures with 39.2 μM 7-ethoxyresorufin in culture media at 37ºC for 4 h. The amount of 
resorufin converted by the enzymes was calculated by measuring the resorufin 
fluorescence in the incubation media at 543 nm (excitation)/570nm (emission) against 
resorufin standards using the microplate reader (Tecan Trading AG, Switzerland). 
5.2.4 Drug-induced hepatotoxicity testing 
Hepatocytes cultures were used for drug testing on day 7 and day 14, and treated 
with 25 mM APAP for 24 hours. 5 M APAP stock solution dissolved in Dimethyl 
sulfoxide (DMSO) was diluted with culture medium to the final concentration. The 
DMSO final concentration was less than 1%. Cell viability was measured by MTS assay 
using the CellTilter 96 Aqueous One Solution Reagent (Promega, USA). 
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5.2.5 Statistical method 
The student t-test was used to analyze the statistical significance of the data 
between two groups. One-way Analysis of Variance (ANOVA) was used when there 




5.3.1 Determination of flow rate in perfusion culture 
The perfusion flow rate of the bioreactor was carefully determined. The mean 
wall shear stress at different flow rate (0.018, 0.03, 0.06, 0.1 ml/min) was calculated 
using computational simulation model (Figure 33). All shear stress values were well 
below the critical value (33 mPa).  
 
Figure 33. Mean shear stress experienced by cell culture at various flow rates. (Courtesy 
of Leo Hwa Liang) 
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Further perfusion experiment was conducted to monitor the albumin synthesis 
function at the four flow rates (Figure 34). Albumin synthesis function was the lowest in 
the static culture. Although the perfusion culture at 0.06 and 0.1 ml/min produced the 
highest amount of albumin on day 3 than the rest of the cultures, the albumin functional 
level dropped on day 5 and day 7 to the similar level as the perfusion culture at 0.018 
ml/min. The perfusion culture at 0.03 ml/min was able to maintain the albumin function 
at the highest level on day 5 and day 7. These data also coincided with the experiment in 
the chapter 4 that cell functions can not be maintained in the perfusion culture with the 
flow rate that was suggested in the computational simulation to be well below the critical 




Figure 34. Albumin secretion of hepatocytes at different flowrates. ( ) Static; ( ) 
0.018 ml/min; ( ) 0.03 ml/min; ( ) 0.06 ml/min; ( ) 0.1 ml/min. 0.03 ml/min 
was statistically improved over other flow rates on Day 5 and 7 at p < 0.5 (ANOVA). 
(Courtesy of Susanne Ng) 
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5.3.2 Maintenance of excretory and metabolic functions 
With the perfusion at 0.03 ml/min, we investigated the biliary excretory as well as 
metabolic functions in the immediate-overlay hepatocyte sandwich perfusion culture. The 
biliary excretion of fluorescein was intensively observed in both static and perfusion 
culture (Figure 35A and B). The apical repolarization and the Mrp2 localization in the 
perfusion culture were similar to those in static conditions 36 hours after perfusion 
initiation (Figure 35C and D). It suggested that hepatocyte polarity and excretory 
functions were well maintained in our perfusion system. 
 
 
Figure 35. Hepatocyte repolarization and functional maintenance under perfusion 
condition. Left column: static; right column: perfusion. (A) and (B): Localization of 
fluorescein, a dye excreted by hepatocytes. (C) and (D): Immunostaining of apical 
transporter Mrp2 (red) with baso-lateral marker CD147 (green). Arrows point to the 
Mrp2 localized at the bile canaliculi. (Courtesy of Susanne Ng) 
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We monitored the functional maintenance of hepatocytes during a period of 
fifteen days. The albumin secretion and urea production of the hepatocytes in the 
perfusion culture were amplified at approximately 3 and 2 folds over those in the static 
culture throughout the whole culture period (Figure 36A and B). The EROD CYP activity 
(normalized as folds relative to freshly isolated hepatocytes) of hepatocytes in the 
perfusion culture recovered to about 2 times of the freshly isolated levels after 1 week; 
while that in the static culture dropped steadily to zero (Figure 36C). These results 
indicated that high levels of liver-specific functions of the hepatocytes in the perfusion 








Figure 36. (A): Albumin secretion; (B): urea production; (C): normalized EROD CYP 
activity relative to freshly isolated hepatocytes. Static culture is shown in white bar and 
perfusion culture is shown in grey bar. (Courtesy of Susanne Ng) 
 
5.3.3 Consistent drug testing result at different time point during two-week perfusion 
culture 
APAP was used to treat the hepatocyte culture to verify the efficacy of our 
hepatocyte sandwich perfusion system for drug toxicity testing. Hepatocytes in both static 
and perfusion conditions were cultured for two weeks after perfusion initiation. 
Hepatocytes cultured on day 7 or day 14 were treated with APAP for 24 hours and cell 
viability was assessed by MTS assay. There was no significant difference of the cell 
viability of the perfusion culture whether APAP treatment of the cells were performed at 
day 7 (45%) and day 14 (38%) (Figure 37). However, the cell viability in the static 
culture dropped significantly from day 7 (70%) to day 14 (43%), likely due to the loss of 
drug metabolic functions in the static culture after two weeks. The results demonstrated 
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the consistency of drug response in the perfusion culture at different time points during 
two-week culture period. 
 
Figure 37.  Cell viability after 25mM APAP treatment for 24 hours at day 7 and day 14. 
Cell culture without APAP treatment is shown in white bar, the static sandwich culture 
with APAP treatment is shown in grey bar and the perfusion sandwich culture with 
APAP treatment is shown in black bar. % viability represents the cell viability 
normalized to the values without APAP treatment. Asterisk indicates statistical difference 
at p < 0.5 (t-test) between the two groups. NSF indicates no statistical difference. 
 
5.4 Discussion 
The sandwich culture is able to maintain cell functions since cell polarity is re-
established to effectively expel toxin from intracellular region. However, it was found 
that some toxins can inhibit transporter activity even when excreted outside the cells. For 
example, progesterone can trans-inhibit Bsep activity after excretion into bile canaliculi 
so that further excretion via Bsep is prohibited and toxic substance would start to build up 
intra-cellularly [90]. This may explain one of the possible mechanisms that the long term 
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exposure of toxic metabolites to hepatocyte culture may also affect cell functions. 
Perfusion culture possibly works better by helping to remove the wastes from the extra-
cellular local environment after secretion from the cells. Our results support this 
possibility since the liver-specific functions were maintained for up to 15 days only in the 
sandwich perfusion culture where wastes in both intra-cellular and extra-cellular 
environment were effectively removed. 
 
Liver-specific functions, especially phase I drug metabolic function (e.g. EROD 
activity) could be maintained in our sandwich perfusion system for up to 15 days. APAP 
was used as a model drug to test the feasibility and sensitivity of the system in drug 
testing application. Both phase I (CYP2E1) and phase II (glucuronide, sulfate or 
glutathione conjugation) drug metabolic pathways are involved in APAP metabolism to a 
non-toxic form, and the intermediate, N-acetyl-p-benzoquinoneimine (NAPQI), produced 
after phase I metabolism, is toxic [150]. The perfusion culture exhibited a higher 
sensitivity to APAP-induced toxicity than the static culture on both day 7 and day 14 
(Figure 37), attributable to the higher drug metabolic functions of the sandwich perfusion 
culture. Approximately 60% of cell death was observed in the perfusion culture treated 
with 25mM of APAP for 24 hours. This observation was similar to the finding that Wang 
et. al. and Mingoia et. al.  reported the APAP IC50 value (the drug concentration causing 
50% of cell death) obtained from their hepatocyte culture system to be 14.01mM and 
20.42mM, respectively [151, 152]. Furthermore, the cell viability in the perfusion culture 
after APAP treatment on day 7 and day 14 was similar (Figure 37). In contrast, static 
culture treated with APAP on day 7 and day 14 produced highly variable cell viability 
 114
results (Figure 37). Static hepatocyte sandwich cultures for 3 to 5 days were typically 
used by many groups to perform toxicological studies [10-12]. Our sandwich perfusion 
system extended the usable period of in vitro hepatocyte culture up to 15 days with 
consistent drug response at different time point during the culture periods. Instead of 
using cells from different batches of isolation which may cause batch-to-batch variation, 
we could combine a large number of isolated hepatocytes for long-term culture in the 
immediate-overlay sandwich perfusion system. One aliquot of the cultured cells can be 
used for functional validation while the rest of the combined lot can be ready for drug 
testing at any required time points. This would enable the industry-scale drug testing with 
improved consistency without the limitations of the current pooled and freeze protocols. 
 
5.5 Conclusion 
In this chapter, we integrated hepatocyte sandwich culture with the perfusion 
bioreactor in the perfusion condition which was carefully selected in terms of flow rate. 
The cultured hepatocytes exhibited restored hepatocyte polarity and biliary excretion, and 
maintained liver-specific functions for two weeks. Cells could produce consistent drug 
toxicity responses at different time points during the culture. The results demonstrated 
hepatocyte sandwich perfusion culture can extend the usage period of in vitro hepatocyte 
culture with maintained liver-specific functions for hepatotoxicity study. Our system can 
be further exploited in industry-scale drug testing. 
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6 Conclusion 
This thesis has documented the implementation of hepatocyte sandwich perfusion 
culture in the application of BLAD and drug testing.  
 
Firstly, the significance of hepatocyte polarity in maintenance of liver-specific 
functions was evaluated in the presence of endogenous toxic metabolites. We identified 
unconjugated bilirubin and taurocholate as two model toxins for cell treatment. We 
determined the concentration for cell treatment to be 100uM for unconjugated bilirubin 
and 500uM for taurocholate. ECCD-1 was used to block polarity formation in the 
sandwich culture. With the treatment of model toxins, albumin synthesis function was 
significantly lower in the sandwich culture without polarity formation than that of normal 
sandwich culture.  
 
Secondly, we developed a sandwich culture based stacked-plate bioreactor for 
BLAD. The new bioreactor design overcame some persistent problems of current flat 
plate configuration including cell packing density, scalability and the regulation of flow 
profile. The perfusion condition, such as oxygenation and flow rate, was carefully 
determined with the incorporation of sandwich culture based stacked-plate bioreactor in 
the perfusion loop. In vitro test indicated that the bioreactor were able to maintained high 
level of functions and polarity for seven days. The efficacy of the sandwich culture based 
bioreactor to maintained liver-specific functions and polarity was evident, suggesting that 
the bioreactor is ready for further in vivo test on animal models. 
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Finally, for the application of drug testing, we integrated hepatocyte sandwich 
culture with a specifically designed single-chamber perfusion bioreactor. The cultured 
hepatocytes exhibited restored hepatocyte polarity and biliary excretion, and maintained 
liver-specific functions for two weeks. Cells could produce consistent drug toxicity 
responses at different time points during the culture, suggesting that hepatocyte sandwich 
perfusion culture can extend the usage period of in vitro hepatocyte culture with 
maintained liver-specific functions for hepatotoxicity study. This sandwich perfusion 
system can be further exploited in industry-scale drug testing. 
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7 Recommendations for future study 
7.1 In vivo test of hepatocyte sandwich culture based stacked plate bioreactor in 
animal model  
In chapter 4, the sandwich culture based stacked-plate bioreactor was successfully 
undergone in vitro test. For the next phase, in vivo animal test can be performed on the 
bioreactor in rat or pig model. Animal models with FHF can be created with either 
hepatectomy [153] or drug induction [154]. Hepatocytes were cultured and stabilized in 
the bioreactor before connecting to the animal body for test. The extracorporeal perfusion 
loop needs to be modified for in vivo test [155]. The animal blood would be drained to a 
plasma separator where blood cells and plasma are separated. Subsequently, only the 
plasma is perfused through the bioreactor loop for treatment. After the exchange of 
metabolites between the cultured hepatocytes in the bioreactor and the plasma, the 
plasma is perfused back to the plasma separator to reconstitute the whole blood with the 
blood cells and drained back to the body. FHF animal without bioreactor treatment and 
with bioreactor that does not contain hepatocytes would be used for control purpose. 
Physiological parameters and blood biochemistry, which include prothrombin time (PT), 
systolic blood pressure, arterial pH, aspartate aminotransferase (AST), alanine 
aminotransferase (ALT), branched chain amino acids, aromatic amino acids, ammonia, 
blood glucose, creatinine, direct and total bilirubin, would be measure before, during and 
after the treatment [106, 155, 156]. The survival rate would be calculated to evaluate the 
efficacy of the treatment. The hepatocyte viability and functions in the bioreactor would 
also be assessed after the treatment to evaluate the effect of sandwich culture in 
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maintenance of cell viability and functions in the real scenario where toxic plasma is 
present.  
 
7.2 Incorporation of synthetic sandwich culture with stacked plate bioreactor for 
BLAD  
In chapter 4, the bioreactor based on collagen sandwich culture has been 
developed for BLAD application. However, there are several problems pertaining to the 
collagen sandwich culture. Firstly, collagen is animal-derived materials. If collagen is 
used in medical devices, it may raise the risk of immune response or rejection and 
introduce xenogenous pathogen to the human body. Secondly, the collagen coating layer 
acted as a mass transfer barrier that hindered the effective exchange of nutrients, 
metabolites and wastes between cells and the surrounding medium. The use of synthetic 
sandwich culture may solve these problems in the collagen sandwich. Instead of 
sandwich between two collagen layer, hepatocytes in the synthetic sandwich culture were 
seeded on galactose modified bottom substratum and overlaid with arginine-glycine-
aspartic acid (RGD) peptide modified top substratum [135]. Both galactose and RGD are 
chemically synthesized, which eliminates the concern of xenogenous elements. The 
improvement of mass transfer in synthetic sandwich over collagen sandwich was also 
evident. Synthetic sandwich culture was able to maintain long term liver-specific 
functions comparable to collagen sandwich.  
 
We have further assessed the maintenance of hepatocyte polarity in the synthetic 
sandwich culture (Appendix 8.3) and explored the synthetic sandwich perfusion culture 
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for long term functional maintenance (Appendix 8.4). The preliminary data indicated that 
the synthetic sandwich culture was able to maintain hepatocyte polarity for long term in a 
comparable manner to the collagen sandwich. Synthetic sandwich can be further 
implemented in the bioreactor for perfusion culture in which hepatocyte functions were 
enhanced. Therefore, the synthetic sandwich can be scaled up and incorporated in our 
stacked plated bioreactor for the second generation of BLAD. Relevant in vitro and in 
vivo testing can be tested based on the new generation.  
 
7.3 Evaluation of hepatocyte sandwich perfusion system as liver in vitro model for 
drug testing application 
In chapter 5, the hepatocyte sandwich perfusion system has been established for 
drug testing application and APAP was used as a model drug for the study. The use of 
system in drug testing can be further expanded to other aspects of the area. Besides the 
test of drug toxicity on cell viability, other toxicological and pharmacological studies 
may also be applied in our system, such as drug metabolism and drug interaction with 
CYPs or transporters [157]. A drug may interact with CYP and induce its activity, which 
would either reduce the pharmacological effects of the drug due to rapid clearance of its 
effective form, or increase drug toxicity by producing more reactive intermediates [158, 
159]. Some drugs may covalently bind to the efflux transporter and inactivate its 
excretory activity so that the excretion of its specific substrates mediated by the 
transporter is inhibited and intracellular accumulation of these substrates would lead to 
cell toxicity [90].  
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RT-PCR and western blot can be used to evaluate the expression of CYPs and 
transporters in transcriptional and translational level [160]. The activities of CYPs and 
transporter can be measured using their specific substrates, e.g. EROD for CYP1A1/A2, 
ECOD for CYP2E1,  PROD for CYP2B [161] and FDA for Mrp2 [162], Rhodamine 123 
for Mdr [163]. Various doses of drugs can be fed to the cells cultured in the sandwich 
perfusion system over a certain period of time (24 hrs or 48 hrs). CYPs or transporters 
activity can be measured after the drug administration. Subsequently, the cells can be 
harvested for mRNA or protein extraction to assess the change of CYPs and transporters 




8.1 Collagen deposition on PET film 
 
Figure 38. Collagen deposition on the glass coverslip (A,C) and PET film (B,D): (A),(B): 
back-scattering image. The number at the lower right corner is the percentage of collagen 
deposition area normalized to total surface area. (C),(D): phase contrast image. 
 
For normal practice of hepatocyte sandwich culture, collagen was coated on 
culture dishes [53] or glass coverslips [121]. Both culture plate and coverslips (too fragile) 
were not applicable in bioreactor perfusion culture. Collagen coating on the PET film was 
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investigated and the amount of collagen deposition on the PET surface was compared 
with that on the coverslip (Figure 38). Collagen fibers were extensively deposition on the 
surface of both coverslip and PET film. The quantification data indicated that the amount 
of collagen deposition was similar on two types of surfaces. The results suggested 
collagen fibers were able to adsorb on PET film ready for hepatocyte attachment.  
 
8.2 Investigation of double-cell-layer sandwich 
The seeding method was called double-cell-layer sandwich. In this configuration, 
two layers of cells were cultured in single sandwich. To enhance the mass transfer 
property, we used synthetic sandwich culture [135], instead of collagen sandwich culture, 
to investigate the new configuration. Briefly, hepatocytes were seeded on galactose 
modified PET film (PET-Gal) as well as RGD modified PET membrane (PET-RGD). 
Cell seeding density on each surface was 0.4 million/cm2 to achieve ~100% confluence.  
After one day, PET-RGD membrane with cells was overlaid on cell-seeded PET-Gal film. 
Cell morphology and functions were investigated. Three configurations were compared: 
1. sandwich culture with single cell layer with 0.4 million/cm2 cell seeding density 
(Single-cell-layer sandwich); 2. sandwich culture with direct seeding density of 0.8 
million/cm2 on bottom PET-Gal film (pseudo double-cell-layer sandwich); 3 double-cell-





Figure 39. Cell morphology of two days after overlay using f-actin staining (A-C) and 
phase contrast images (D-F). (A),(D). Single-cell-layer sandwich with normal density 
(0.4million/cm2). (B),(E). Pseudo double-cell-layer sandwich with double density 
(0.8million/cm2).  (C),(F). Double-cell-layer sandwich with normal density 
(0.4million/cm2) on both PET-Gal and PET-RGD.  
 
In both pseudo double-cell-layer sandwich and double-cell-layer sandwich, cell 
aggregates was formed. Cells did not form a perfect double-cell-layer due to the 
spreading and migration of cells in the culture (Figure 39B,C). In the single-cell-layer 
sandwich, cell-cell interaction was observed. Some cells did not spread and they formed 



























































Figure  40. Albumin synthesis (A) and urea production (B) function in single-
cell-layer and double-cell layer sandwich. Black bar: Single-cell-layer sandwich. Grey 
bar: Psuedo double-cell-layer sandwich. White bar: Double-cell-layer sandwich.  
 
The total cell functions per sandwich culture were calculated. Although the cell 
number was doubled in both pseudo double-cell-layer sandwich and double-cell-layer 
sandwich, albumin synthesis level on day 2 (Figure 40A) and urea production level on 
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day 2 and day 4 (Figure 40B) were similar as those of single-cell-layer sandwich. Since 
the advantages of the sandwich culture is to mimic in vivo liver structure where both cell-
cell and cell-matrix interactions are present, the aggregate formation in double-cell-layer 
sandwich compromised the cell-matrix interaction and flat cell layer morphology. 
Therefore, the double in cell number in the sandwich culture does not necessarily lead to 
double in cell functions. The double-cell-layer sandwich was not suitable to be used as a 
seeding method in BLAD application. 
 
8.3 Maintenance of hepatocyte polarity in synthetic sandwich 
We investigated the maintenance of hepatocyte polarity in synthetic sandwich in a 
culture period of five days. Collagen sandwich was used as the control. F-actin 
establishes the structural polarity. The extensive formation of bile canaliculus network 
can be observed in both collagen and synthetic sandwich cultures (Figure 41). The red 
fluorescence was more intensive near the bile canaliculus region indicating that more f-
actin was deposited around that area for bile contraction. The apical transporter, Mrp2, 
was localized on the cell boundary region in synthetic sandwich on day 1 (Figure 42D), 
and the localization was more concentrated on day 3 (Figure 42E). Although the amount 
of Mrp2 was decreased on day 5 (Figure 42F), they were still observed on the apical 
domain. The trend of Mrp2 localization in synthetic sandwich was similar as that in 
collagen sandwich (Figure 42A-C). FDA excretion mediated by Mrp2 indicated the 
functional polarity. FDA was localized near the bile canalicular region upon excretion 
and the intensive FDA fluorescence localization was observed on day 3 in both collagen 
and synthetic sandwich, which was coincide with the peak of Mrp2 localization on day 3 
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(Figure  43). The results suggested that the polarity re-established in synthetic sandwich 
was comparable to that in the collagen sandwich.  
 




Figure 42. Mrp2 (Red)/CD147 (Green) co-staining of collagen sandwich (A-C) and 
synthetic sandwich (D-F). (A),(D): Day 1, (B),(E): Day 3, (C),(F): Day 5 
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Figure 43. FDA excretion in collagen sandwich (A-C) and synthetic sandwich (D-F). 
(A),(D): Day 1, (B),(E): Day 3, C,F: Day 5 
 
 
Figure 44. The schematic of vertical perfusion bioreactor for synthetic sandwich 
perfusion culture 
8.4 Functional maintenance in synthetic sandwich perfusion culture 
Hepatocyte function in the synthetic sandwich perfusion culture was investigated. 
Synthetic sandwich culture was perfused in the vertical perfusion bioreactor (Figure 44). 
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Albumin synthesis and urea production functions were monitored every two days for one 
week. Both albumin and urea level in the perfusion culture were higher than those in the 
static culture during 7-day culture period (Figure 45A,B). The results indicated that the 
synthetic sandwich perfusion culture was able to maintain better liver-specific functions 































































Figure 45. Albumin synthesis (A) and urea production (B) function in the synthetic 
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